MNK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A6NKT7 | S980 | Sugiyama | RGPD3 RGP3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O00571 | S83 | Sugiyama | DDX3X DBX DDX3 | sKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRsD |
| O14641 | T652 | Sugiyama | DVL2 | RRGGEAsGtsDGGPPPsRGstGGAPNLRAHPGLHPYGPPPG |
| O14715 | S979 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O14974 | S445 | Sugiyama | PPP1R12A MBS MYPT1 | EEERKDEsPATWRLGLRKtGsyGALAEItASKEGQKEKDTA |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O43597 | S112 | EPSD|PSP | SPRY2 | PRLQHSQVHSSARAPLSRSIsTVsSGSRSsTRTSTSSSSSE |
| O43597 | S121 | EPSD|PSP | SPRY2 | SSARAPLSRSIsTVsSGSRSsTRTSTSSSSSEQRLLGssFs |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75348 | S68 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | RLQREKEFKAKEAAALGsRGsCstEVEKETQEKMTILQtyF |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O76070 | S9 | Sugiyama | SNCG BCSG1 PERSYN PRSN | ____________MDVFKKGFsIAKEGVVGAVEKTKQGVTEA |
| O95218 | S143 | Sugiyama | ZRANB2 ZIS ZNF265 | EyDEFGRKKKKYRGKAVGPAsILKEVEDKEsEGEEEDEDED |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| O95297 | S260 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | IyAQLDHsGGHHSDKINKSEsVVyADIRKN___________ |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O96013 | S41 | Sugiyama | PAK4 KIAA1142 | VHTGFDQHEQKFTGLPRQWQsLIEESARRPKPLVDPACITS |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04792 | S15 | Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06730 | S209 | SIGNOR|ELM|iPTMNet|EPSD|PSP | EIF4E EIF4EL1 EIF4F | LPPKIVIGyQsHADTAtKsGsttKNRFVV____________ |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07711 | S301 | Sugiyama | CTSL CTSL1 | VGYGFESTESDNNKYWLVKNsWGEEWGMGGyVKMAKDRRNH |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S330 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KHRKNPIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGC |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S482 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sGDEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVER |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S192 | GPS6|EPSD | HNRNPA1 HNRPA1 | GHNCEVRKALSKQEMAsAsssQRGRsGsGNFGGGRGGGFGG |
| P09651 | S362 | GPS6|EPSD | HNRNPA1 HNRPA1 | GGGGQyFAKPRNQGGyGGssssssyGsGRRF__________ |
| P09651 | S363 | GPS6|EPSD | HNRNPA1 HNRPA1 | GGGQyFAKPRNQGGyGGssssssyGsGRRF___________ |
| P09651 | S364 | GPS6|EPSD | HNRNPA1 HNRPA1 | GGQyFAKPRNQGGyGGssssssyGsGRRF____________ |
| P09972 | S17 | Sugiyama | ALDOC ALDC | ____MPHSYPALSAEQKKELsDIALRIVAPGKGILAADEsV |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DJD0 | S964 | Sugiyama | RGPD1 RANBP2L6 RGP1 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P12004 | S152 | Sugiyama | PCNA | EySCVVKMPSGEFARICRDLsHIGDAVVIsCAKDGVKFSAs |
| P12004 | S161 | Sugiyama | PCNA | SGEFARICRDLsHIGDAVVIsCAKDGVKFSAsGELGNGNIK |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13797 | S540 | Sugiyama | PLS3 | NDDIIVNWVNRTLSEAGKSTsIQSFKDKTISSSLAVVDLID |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13984 | S28 | Sugiyama | GTF2F2 RAP30 | DLTGAKQNtGVWLVKVPKYLsQQWAKASGRGEVGKLRIAKT |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | S674 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | WsGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLI |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15328 | S79 | Sugiyama | FOLR1 FOLR | PWRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRH |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | S249 | Sugiyama | RPS2 RPS4 | CtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEF |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18615 | S113 | Sugiyama | NELFE RD RDBP | EGKLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLy |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20290 | S173 | Sugiyama | BTF3 NACB OK/SW-cl.8 | QLGADsLtsLRRLAEALPKQsVDGKAPLAtGEDDDDEVPDL |
| P21333 | S1029 | Sugiyama | FLNA FLN FLN1 | VGPSGAAVPCKVEPGLGADNsVVRFLPREEGPYEVEVTYDG |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23246 | S283 | EPSD|PSP|Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23246 | S8 | EPSD|PSP | SFPQ PSF | _____________MSRDRFRsRGGGGGGFHRRGGGGGRGGL |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23528 | S41 | Sugiyama | CFL1 CFL | RKsstPEEVKKRKKAVLFCLsEDKKNIILEEGKEILVGDVG |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P26038 | S429 | Sugiyama | MSN | DQKKTQEQLALEMAELtARIsQLEMARQKKEsEAVEWQQKA |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26639 | S282 | Sugiyama | TARS1 TARS | RGPHVRHTGKIKALKIHKNssTyWEGKADMETLQRIyGISF |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | S443 | Sugiyama | TKT | EDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAAN |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30622 | S193 | Sugiyama | CLIP1 CYLN1 RSN | QPAAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELK |
| P30622 | S195 | Sugiyama | CLIP1 CYLN1 RSN | AAKEPsAtPPISNLTKtAsEsIsNLsEAGsIKKGERELKIG |
| P31939 | S202 | Sugiyama | ATIC PURH OK/SW-cl.86 | tAQyDEAISDyFRKQYSKGVsQMPLRyGMNPHQtPAQLytL |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S363 | Sugiyama | HSPA4 APG2 HSPH2 | GATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAIL |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35637 | S462 | Sugiyama | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39023 | S304 | Sugiyama | RPL3 OK/SW-cl.32 | IYKIGQGyLIKDGKLIKNNAstDyDLSDKSINPLGGFVHYG |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P46937 | T114 | Sugiyama | YAP1 YAP65 | sFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQL |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49790 | S607 | Sugiyama | NUP153 | KtPPEDCEGPFRPAEILKEGsVLDILKsPGFAsPKIDSVAA |
| P49792 | S1955 | Sugiyama | RANBP2 NUP358 | GVIFGQTSSTFTFADLAKstsGEGFQFGKKDPNFKGFSGAG |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53634 | S428 | Sugiyama | CTSC CPPI | LLVGYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDEC |
| P53999 | S57 | Sugiyama | SUB1 PC4 RPO2TC1 | VKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRDF |
| P54577 | S338 | Sugiyama | YARS1 YARS | NKLLDPIREKFNTPALKKLAsAAYPDPSKQKPMAKGPAKNs |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61604 | S51 | Sugiyama | HSPE1 | IMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsVKVGDKV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | T70 | Sugiyama | HNRNPK HNRPK | QSKNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsI |
| P62072 | S48 | Sugiyama | TIMM10 TIM10 | ACHRKCVPPHYKEAELSKGEsVCLDRCVSKYLDIHERMGKK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62714 | S43 | Sugiyama | PPP2CB | LNENQVRTLCEKAKEILTKEsNVQEVRCPVTVCGDVHGQFH |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67775 | S43 | Sugiyama | PPP2CA | LSESQVKSLCEKAKEILTKEsNVQEVRCPVTVCGDVHGQFH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | S175 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | MDSTEPPySQKRYEEIVKEVsTyIKKIGYNPDTVAFVPISG |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S9 | Sugiyama | RPL24 | ____________MKVELCsFsGyKIYPGHGRRYARTDGKVF |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00341 | S904 | Sugiyama | HDLBP HBP VGL | FHRSVMGPKGSRIQQITRDFsVQIKFPDREENAVHSTEPVV |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00839 | S267 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KRPREDHGRGyFEyIEENKysRAKsPQPPVEEEDEHFDDtV |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q06210 | T263 | Sugiyama | GFPT1 GFAT GFPT | QGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDASA |
| Q06830 | S32 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | APNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVC |
| Q07352 | S84 | Sugiyama | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | QNQLLSsLKGEPAPALSSRDsRFRDRsFsEGGERLLPTQKQ |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q12965 | S1002 | Sugiyama | MYO1E MYO1C | RSNQKSLyTsMARPPLPRQQstssDRVsQtPEsLDFLKVPD |
| Q13263 | S138 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | PVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCCTSCED |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13573 | S182 | Sugiyama | SNW1 SKIIP SKIP | AMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEM |
| Q14247 | S332 | Sugiyama | CTTN EMS1 | VQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRA |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q14980 | S1183 | Sugiyama | NUMA1 NMP22 NUMA | ALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHS |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15149 | S4642 | EPSD|PSP | PLEC PLEC1 | stAGsRtGsRtGsRAGsRRGsFDAtGsGFsMtFSsssYSSS |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15398 | S15 | Sugiyama | DLGAP5 DLG7 KIAA0008 | ______MSSSHFASRHRKDIsTEMIRTKIAHRKSLSQKENR |
| Q15417 | S259 | Sugiyama | CNN3 | DNSTISLQMGTNKVAsQKGMsVyGLGRQVYDPKYCAAPTEP |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF8 | S258 | Sugiyama | HSP90AB2P HSP90BB | LAVRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQ |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SW79 | S873 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | IPHINKQTsstPssLALtsAsRIRERsEsLDPDssMDTtLI |
| Q5SYE7 | S1495 | Sugiyama | NHSL1 C6orf63 KIAA1357 | KNRRAQEEWAKNEGLMPRsLsFsGPRYGRSRTPPSAASSRY |
| Q5VTE0 | S175 | Sugiyama | EEF1A1P5 EEF1AL3 | MDSTEPPySQKRYEEIVKEVsTyIKKIGYNPDTVAFVPISG |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z3J3 | S980 | Sugiyama | RGPD4 RGP4 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z460 | S545 | Sugiyama | CLASP1 KIAA0622 MAST1 | yHTLESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNR |
| Q7Z5L9 | S455 | Sugiyama | IRF2BP2 | AGGSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVG |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V48 | S878 | Sugiyama | LUZP1 | AERMADGPLKDRPETVVSRssIIIKPSDPVERNSHAPPAET |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N684 | S166 | Sugiyama | CPSF7 | PGKVLNGEKVDVRPAtRQNLsQFEAQARKRECVRVPRGGIP |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBP7 | S487 | Sugiyama | PCSK9 NARC1 PSEC0052 | PTRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKL |
| Q8NBS9 | S292 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSEAPV |
| Q8NEZ2 | S18 | Sugiyama | VPS37A HCRP1 | ___MSWLFPLTKsAsssAAGsPGGLTSLQQQKQRLIESLRN |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q92945 | S333 | Sugiyama | KHSRP FUBP2 | DRNEyGsRIGGGIDVPVPRHsVGVVIGRSGEMIKKIQNDAG |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96GQ7 | S79 | Sugiyama | DDX27 cPERP-F RHLP HSPC259 PP3241 | EEEEGPIVLGRRQKALGKNRsADFNPDFVFTEKEGTyDGsW |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96IZ0 | S231 | Sugiyama | PAWR PAR4 | SsyLLQEPPRTVSGRyKsttsVsEEDVsSRYsRTDRSGFPR |
| Q96IZ0 | Y226 | Sugiyama | PAWR PAR4 | LLDPGSsyLLQEPPRTVSGRyKsttsVsEEDVsSRYsRTDR |
| Q96PE3 | S788 | Sugiyama | INPP4A | FNVRVPLPGPLFDALPREIQsGMLLRVQPVLFNVGINEQQT |
| Q99575 | S816 | Sugiyama | POP1 KIAA0061 | VAATGSHLCVLRSRKLLKQLsAWCGPSSEDSRGGRRAPGRG |
| Q99666 | S979 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BT09 | S205 | Sugiyama | CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409 | QEEDLTEFLCANHVLKGKDtsCLAEQWsGKKGDTAALGGKK |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9HBH9 | S166 | Sugiyama | MKNK2 GPRK7 MNK2 | IEFFEEEDRFYLVFEKMRGGsILSHIHKRRHFNELEASVVV |
| Q9HBH9 | S338 | Sugiyama | MKNK2 GPRK7 MNK2 | LFESIQEGKYEFPDKDWAHIsCAAKDLISKLLVRDAKQRLS |
| Q9HBH9 | S394 | Sugiyama | MKNK2 GPRK7 MNK2 | ENTLPTPMVLQRNSCAKDLTsFAAEAIAMNRQLAQHDEDLA |
| Q9HBH9 | S431 | Sugiyama | MKNK2 GPRK7 MNK2 | EDLAEEEAAGQGQPVLVRAtsRCLQLsPPsQsKLAQRRQRA |
| Q9HBH9 | S437 | Sugiyama | MKNK2 GPRK7 MNK2 | EAAGQGQPVLVRAtsRCLQLsPPsQsKLAQRRQRAsLssAP |
| Q9HBH9 | S440 | Sugiyama | MKNK2 GPRK7 MNK2 | GQGQPVLVRAtsRCLQLsPPsQsKLAQRRQRAsLssAPVVL |
| Q9HBH9 | S442 | Sugiyama | MKNK2 GPRK7 MNK2 | GQPVLVRAtsRCLQLsPPsQsKLAQRRQRAsLssAPVVLVG |
| Q9HBH9 | S452 | Sugiyama | MKNK2 GPRK7 MNK2 | RCLQLsPPsQsKLAQRRQRAsLssAPVVLVGDHA_______ |
| Q9HBH9 | S454 | Sugiyama | MKNK2 GPRK7 MNK2 | LQLsPPsQsKLAQRRQRAsLssAPVVLVGDHA_________ |
| Q9HBH9 | S455 | Sugiyama | MKNK2 GPRK7 MNK2 | QLsPPsQsKLAQRRQRAsLssAPVVLVGDHA__________ |
| Q9HBH9 | S74 | Sugiyama | MKNK2 GPRK7 MNK2 | IDIPDAKKRGKKKKRGRAtDsFsGRFEDVYQLQEDVLGEGA |
| Q9HBH9 | T430 | Sugiyama | MKNK2 GPRK7 MNK2 | DEDLAEEEAAGQGQPVLVRAtsRCLQLsPPsQsKLAQRRQR |
| Q9HBH9 | T72 | Sugiyama | MKNK2 GPRK7 MNK2 | QPIDIPDAKKRGKKKKRGRAtDsFsGRFEDVYQLQEDVLGE |
| Q9HCN8 | S40 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | ALLVPGGGAAKTGAELVTCGsVLKLLNTHHRVRLHSHDIKY |
| Q9NP61 | S212 | Sugiyama | ARFGAP3 ARFGAP1 | EQGPSVEGLNVPTKATLEVssIIKKKPNQAKKGLGAKKGSL |
| Q9NP61 | S437 | Sugiyama | ARFGAP3 ARFGAP1 | AQKKFGNVKAIssDMyFGRQsQADYETRARLERLsAsssIs |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NYF8 | S319 | Sugiyama | BCLAF1 BTF KIAA0164 | RsPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKR |
| Q9NYF8 | S320 | Sugiyama | BCLAF1 BTF KIAA0164 | sPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKRF |
| Q9NZL9 | S16 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | _____MVGREKELsIHFVPGsCRLVEEEVNIPNRRVLVtGA |
| Q9NZL9 | S9 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | ____________MVGREKELsIHFVPGsCRLVEEEVNIPNR |
| Q9UHA3 | S68 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | KVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRELWNK |
| Q9UHB6 | S617 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | FQstsVKsPKtVsPPIRKGWsMsEQSEESVGGRVAERKQVE |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UK32 | S389 | Sugiyama | RPS6KA6 RSK4 | PKDsPGLPAsANAHQLFKGFsFVAtsIAEEYKITPITSANV |
| Q9UK32 | S394 | Sugiyama | RPS6KA6 RSK4 | GLPAsANAHQLFKGFsFVAtsIAEEYKITPITSANVLPIVQ |
| Q9ULX3 | S390 | Sugiyama | NOB1 ART4 NOB1P PSMD8BP1 MSTP158 | VsPFVENDISSRSATLQVRDsTLGAGRRRLNPNASRKKFVK |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2W1 | S232 | Sugiyama | THRAP3 BCLAF2 TRAP150 | QDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPALK |
| Q9Y2W1 | S237 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sEssKPWPDAtyGtGsAsRAsAVsELsPRERsPALKsPLQs |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 1.240722e-08 | 7.906 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.945707e-08 | 7.711 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.243485e-08 | 7.140 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.973503e-07 | 6.527 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.235528e-07 | 6.373 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.247021e-07 | 6.280 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.127462e-06 | 5.948 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.109782e-06 | 5.091 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.770183e-05 | 4.752 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.575272e-05 | 4.803 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.692840e-05 | 4.771 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.707401e-05 | 4.431 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.258305e-05 | 4.279 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.400496e-05 | 4.268 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.621753e-05 | 4.250 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.824861e-05 | 4.235 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.094156e-05 | 4.149 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.120301e-05 | 4.090 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.091686e-05 | 4.092 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.651114e-05 | 4.063 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.768695e-05 | 4.057 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.934775e-05 | 4.003 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.005685e-04 | 3.998 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.400250e-04 | 3.854 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.517117e-04 | 3.819 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.525398e-04 | 3.817 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.543233e-04 | 3.812 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.653657e-04 | 3.782 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.692374e-04 | 3.772 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.692374e-04 | 3.772 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.786611e-04 | 3.748 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.927000e-04 | 3.715 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.057364e-04 | 3.687 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.415644e-04 | 3.617 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.415644e-04 | 3.617 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.513864e-04 | 3.454 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.616516e-04 | 3.442 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.931762e-04 | 3.405 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.946813e-04 | 3.404 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.963364e-04 | 3.402 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.578059e-04 | 3.339 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.207349e-04 | 3.283 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.125147e-04 | 3.290 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.409962e-04 | 3.267 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.708301e-04 | 3.243 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.613848e-04 | 3.180 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.750787e-04 | 3.058 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.765491e-04 | 3.057 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.468523e-04 | 3.072 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.786934e-04 | 3.056 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.358658e-04 | 3.029 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.090411e-03 | 2.962 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.098724e-03 | 2.959 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.123791e-03 | 2.949 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.138476e-03 | 2.944 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.138476e-03 | 2.944 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.185934e-03 | 2.926 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.238256e-03 | 2.907 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.246992e-03 | 2.904 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.284742e-03 | 2.891 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.321675e-03 | 2.879 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.374228e-03 | 2.862 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.410143e-03 | 2.851 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.441192e-03 | 2.841 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.545450e-03 | 2.811 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.482941e-03 | 2.829 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.798412e-03 | 2.745 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.902863e-03 | 2.721 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.831254e-03 | 2.737 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.831254e-03 | 2.737 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.090680e-03 | 2.680 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.220240e-03 | 2.654 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.220240e-03 | 2.654 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.622069e-03 | 2.581 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.693891e-03 | 2.570 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.019672e-03 | 2.520 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.331367e-03 | 2.477 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.331367e-03 | 2.477 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.192513e-03 | 2.496 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.331367e-03 | 2.477 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.253565e-03 | 2.488 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.263253e-03 | 2.486 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.357995e-03 | 2.474 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.888630e-03 | 2.410 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.828724e-03 | 2.417 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.970418e-03 | 2.401 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.020910e-03 | 2.396 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.705096e-03 | 2.327 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.705096e-03 | 2.327 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.705096e-03 | 2.327 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.705096e-03 | 2.327 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.705096e-03 | 2.327 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.725796e-03 | 2.326 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.140474e-03 | 2.289 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.724779e-03 | 2.242 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.139664e-03 | 2.212 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.790937e-03 | 2.168 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.662296e-03 | 2.176 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.902791e-03 | 2.161 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.999490e-03 | 2.155 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.065195e-03 | 2.151 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 7.479387e-03 | 2.126 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.639835e-03 | 2.117 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.978238e-03 | 2.098 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.247819e-03 | 2.084 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.033339e-03 | 2.095 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.496904e-03 | 2.071 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.597328e-03 | 2.066 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.610599e-03 | 2.065 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 9.436831e-03 | 2.025 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 9.436831e-03 | 2.025 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 9.436831e-03 | 2.025 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 9.436831e-03 | 2.025 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.994158e-03 | 2.046 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.924006e-03 | 2.049 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.829341e-03 | 2.054 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.910357e-03 | 2.050 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.035931e-02 | 1.985 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.035931e-02 | 1.985 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.013287e-02 | 1.994 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.013287e-02 | 1.994 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.013287e-02 | 1.994 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.792512e-03 | 2.009 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.792512e-03 | 2.009 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.015276e-02 | 1.993 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.013287e-02 | 1.994 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.035931e-02 | 1.985 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.028234e-02 | 1.988 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.081496e-02 | 1.966 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.096311e-02 | 1.960 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.108728e-02 | 1.955 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.140013e-02 | 1.943 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.147684e-02 | 1.940 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.149995e-02 | 1.939 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.151962e-02 | 1.939 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.286972e-02 | 1.890 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.238180e-02 | 1.907 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.208794e-02 | 1.918 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.241835e-02 | 1.906 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.191965e-02 | 1.924 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.286972e-02 | 1.890 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.347275e-02 | 1.871 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.348802e-02 | 1.870 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.365163e-02 | 1.865 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.458923e-02 | 1.836 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.477191e-02 | 1.831 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.540393e-02 | 1.812 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.562151e-02 | 1.806 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.587633e-02 | 1.799 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.683365e-02 | 1.774 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.709401e-02 | 1.767 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.742052e-02 | 1.759 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.823626e-02 | 1.739 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.927163e-02 | 1.715 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.927163e-02 | 1.715 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.803288e-02 | 1.744 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.966265e-02 | 1.706 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.000221e-02 | 1.699 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.015875e-02 | 1.696 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.048215e-02 | 1.689 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.102374e-02 | 1.677 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.102374e-02 | 1.677 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.188666e-02 | 1.660 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.208029e-02 | 1.656 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.218513e-02 | 1.654 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.303972e-02 | 1.638 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.303972e-02 | 1.638 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.462572e-02 | 1.609 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.263732e-02 | 1.645 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.411522e-02 | 1.618 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.411522e-02 | 1.618 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.482417e-02 | 1.605 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.386859e-02 | 1.622 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.462572e-02 | 1.609 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.494503e-02 | 1.603 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.578275e-02 | 1.589 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.581089e-02 | 1.588 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.585505e-02 | 1.587 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.635094e-02 | 1.579 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.635094e-02 | 1.579 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.688102e-02 | 1.571 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.688102e-02 | 1.571 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.688102e-02 | 1.571 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.688102e-02 | 1.571 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.688102e-02 | 1.571 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.688102e-02 | 1.571 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.727956e-02 | 1.564 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.828657e-02 | 1.548 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.864991e-02 | 1.543 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.864991e-02 | 1.543 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.752783e-02 | 1.560 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.026447e-02 | 1.519 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.090976e-02 | 1.510 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.852683e-02 | 1.545 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.127805e-02 | 1.505 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.183583e-02 | 1.497 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.207159e-02 | 1.494 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.321275e-02 | 1.479 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.419664e-02 | 1.466 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.427662e-02 | 1.465 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.461302e-02 | 1.461 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.462008e-02 | 1.461 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.602474e-02 | 1.443 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.602474e-02 | 1.443 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.602474e-02 | 1.443 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.606615e-02 | 1.443 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.127653e-02 | 1.384 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.127653e-02 | 1.384 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.915840e-02 | 1.407 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.915840e-02 | 1.407 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.915840e-02 | 1.407 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.915840e-02 | 1.407 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.176639e-02 | 1.379 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.805642e-02 | 1.420 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.058693e-02 | 1.392 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.925173e-02 | 1.406 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.058693e-02 | 1.392 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.805642e-02 | 1.420 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.127653e-02 | 1.384 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.127653e-02 | 1.384 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.882650e-02 | 1.411 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.915840e-02 | 1.407 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.165208e-02 | 1.380 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.326731e-02 | 1.364 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.470559e-02 | 1.350 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.470559e-02 | 1.350 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.557033e-02 | 1.341 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.557033e-02 | 1.341 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.661919e-02 | 1.331 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.814687e-02 | 1.317 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.996424e-02 | 1.301 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.996424e-02 | 1.301 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.207793e-02 | 1.283 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.209948e-02 | 1.283 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.209948e-02 | 1.283 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.209948e-02 | 1.283 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.401975e-02 | 1.267 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 5.573842e-02 | 1.254 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 5.573842e-02 | 1.254 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.573842e-02 | 1.254 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.580655e-02 | 1.253 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.584279e-02 | 1.253 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.599632e-02 | 1.252 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.599632e-02 | 1.252 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.988820e-02 | 1.223 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.988820e-02 | 1.223 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.627420e-02 | 1.179 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.091141e-02 | 1.215 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.281457e-02 | 1.202 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.627420e-02 | 1.179 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.239592e-02 | 1.205 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.107052e-02 | 1.214 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.944062e-02 | 1.226 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.627420e-02 | 1.179 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.784287e-02 | 1.238 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.239592e-02 | 1.205 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.256786e-02 | 1.204 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.988820e-02 | 1.223 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.281126e-02 | 1.202 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.654196e-02 | 1.177 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.708923e-02 | 1.173 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.708923e-02 | 1.173 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.708923e-02 | 1.173 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.708923e-02 | 1.173 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.730229e-02 | 1.172 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.730229e-02 | 1.172 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.730229e-02 | 1.172 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.946428e-02 | 1.158 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.006746e-02 | 1.154 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.031690e-02 | 1.153 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.156033e-02 | 1.145 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.210727e-02 | 1.142 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.210727e-02 | 1.142 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.384770e-02 | 1.132 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.384770e-02 | 1.132 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.385657e-02 | 1.132 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.914272e-02 | 1.102 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.994647e-02 | 1.097 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.994647e-02 | 1.097 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 9.140239e-02 | 1.039 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 9.140239e-02 | 1.039 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.140239e-02 | 1.039 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.140239e-02 | 1.039 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 9.140239e-02 | 1.039 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.173510e-02 | 1.088 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 8.173510e-02 | 1.088 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.406171e-02 | 1.075 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.500244e-02 | 1.022 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.935362e-02 | 1.049 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.356128e-02 | 1.078 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.590705e-02 | 1.066 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.612435e-02 | 1.017 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.620931e-02 | 1.064 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.406171e-02 | 1.075 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.406171e-02 | 1.075 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.610529e-02 | 1.017 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.856374e-02 | 1.053 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.406171e-02 | 1.075 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.173510e-02 | 1.088 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.242191e-02 | 1.034 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.945408e-02 | 1.048 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.612435e-02 | 1.017 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.335014e-02 | 1.030 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.058203e-02 | 1.094 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.717270e-02 | 1.060 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.853673e-02 | 1.006 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.013543e-01 | 0.994 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.021763e-01 | 0.991 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.021763e-01 | 0.991 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.029130e-01 | 0.988 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.029130e-01 | 0.988 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.054144e-01 | 0.977 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.058604e-01 | 0.975 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.061098e-01 | 0.974 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.061098e-01 | 0.974 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.064773e-01 | 0.973 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.110570e-01 | 0.954 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.113893e-01 | 0.953 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.113893e-01 | 0.953 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.113893e-01 | 0.953 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.123820e-01 | 0.949 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.125559e-01 | 0.949 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.183898e-01 | 0.927 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.183898e-01 | 0.927 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.183898e-01 | 0.927 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.183898e-01 | 0.927 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.183898e-01 | 0.927 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.183898e-01 | 0.927 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.183898e-01 | 0.927 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.183898e-01 | 0.927 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.183898e-01 | 0.927 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.183898e-01 | 0.927 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.183898e-01 | 0.927 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.183898e-01 | 0.927 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.183898e-01 | 0.927 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.318584e-01 | 0.880 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.318584e-01 | 0.880 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.318584e-01 | 0.880 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.337286e-01 | 0.874 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.337286e-01 | 0.874 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.235085e-01 | 0.908 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.235085e-01 | 0.908 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.140929e-01 | 0.943 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.275708e-01 | 0.894 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.421007e-01 | 0.847 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.421007e-01 | 0.847 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.373298e-01 | 0.862 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.373298e-01 | 0.862 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.373298e-01 | 0.862 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.366219e-01 | 0.864 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.203321e-01 | 0.920 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.161737e-01 | 0.935 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.138322e-01 | 0.944 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.316739e-01 | 0.881 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.380634e-01 | 0.860 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.232068e-01 | 0.909 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.242955e-01 | 0.906 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.242955e-01 | 0.906 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.380634e-01 | 0.860 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.373298e-01 | 0.862 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.337128e-01 | 0.874 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.203321e-01 | 0.920 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.246133e-01 | 0.904 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.339111e-01 | 0.873 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.337286e-01 | 0.874 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.242955e-01 | 0.906 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.168717e-01 | 0.932 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.267822e-01 | 0.897 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.275708e-01 | 0.894 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.425714e-01 | 0.846 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.425714e-01 | 0.846 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.227695e-01 | 0.652 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.227695e-01 | 0.652 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.227695e-01 | 0.652 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.227695e-01 | 0.652 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.227695e-01 | 0.652 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.227695e-01 | 0.652 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.754731e-01 | 0.756 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.754731e-01 | 0.756 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.754731e-01 | 0.756 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.147964e-01 | 0.502 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.147964e-01 | 0.502 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.147964e-01 | 0.502 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.147964e-01 | 0.502 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.147964e-01 | 0.502 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.147964e-01 | 0.502 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.147964e-01 | 0.502 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.147964e-01 | 0.502 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.147964e-01 | 0.502 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.147964e-01 | 0.502 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.147964e-01 | 0.502 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.147964e-01 | 0.502 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.147964e-01 | 0.502 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.147964e-01 | 0.502 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.147964e-01 | 0.502 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.147964e-01 | 0.502 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.147964e-01 | 0.502 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.147964e-01 | 0.502 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.147964e-01 | 0.502 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.147964e-01 | 0.502 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.209324e-01 | 0.656 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.209324e-01 | 0.656 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.209324e-01 | 0.656 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.209324e-01 | 0.656 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.209324e-01 | 0.656 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.630824e-01 | 0.788 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.630824e-01 | 0.788 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.630824e-01 | 0.788 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.456902e-01 | 0.837 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.456902e-01 | 0.837 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.941297e-01 | 0.712 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.671889e-01 | 0.573 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.671889e-01 | 0.573 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.671889e-01 | 0.573 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.671889e-01 | 0.573 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.671889e-01 | 0.573 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.671889e-01 | 0.573 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.671889e-01 | 0.573 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.671889e-01 | 0.573 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.959317e-01 | 0.402 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.959317e-01 | 0.402 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.959317e-01 | 0.402 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.959317e-01 | 0.402 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.959317e-01 | 0.402 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.959317e-01 | 0.402 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.959317e-01 | 0.402 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.959317e-01 | 0.402 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.959317e-01 | 0.402 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.959317e-01 | 0.402 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.959317e-01 | 0.402 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.959317e-01 | 0.402 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.692832e-01 | 0.771 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.264732e-01 | 0.645 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.264732e-01 | 0.645 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.264732e-01 | 0.645 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.941018e-01 | 0.712 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.941018e-01 | 0.712 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.941018e-01 | 0.712 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.134171e-01 | 0.504 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.134171e-01 | 0.504 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.134171e-01 | 0.504 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.134171e-01 | 0.504 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.459430e-01 | 0.836 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.597369e-01 | 0.585 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.597369e-01 | 0.585 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.597369e-01 | 0.585 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.199547e-01 | 0.658 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.199547e-01 | 0.658 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.199547e-01 | 0.658 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.199547e-01 | 0.658 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 2.199547e-01 | 0.658 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.199547e-01 | 0.658 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.886677e-01 | 0.724 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.573854e-01 | 0.803 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.104296e-01 | 0.677 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.104296e-01 | 0.677 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.104296e-01 | 0.677 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.104296e-01 | 0.677 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.104296e-01 | 0.677 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.104296e-01 | 0.677 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.466494e-01 | 0.608 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.935723e-01 | 0.532 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.935723e-01 | 0.532 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.935723e-01 | 0.532 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.589756e-01 | 0.445 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.589756e-01 | 0.445 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.589756e-01 | 0.445 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.589756e-01 | 0.445 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 3.589756e-01 | 0.445 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.589756e-01 | 0.445 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.589756e-01 | 0.445 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.674639e-01 | 0.330 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.674639e-01 | 0.330 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.674639e-01 | 0.330 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.674639e-01 | 0.330 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.674639e-01 | 0.330 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.674639e-01 | 0.330 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.674639e-01 | 0.330 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.674639e-01 | 0.330 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.733831e-01 | 0.761 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.002017e-01 | 0.699 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.002017e-01 | 0.699 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.329471e-01 | 0.633 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.739963e-01 | 0.562 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.197459e-01 | 0.658 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.561036e-01 | 0.592 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.957373e-01 | 0.708 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.398931e-01 | 0.620 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.398931e-01 | 0.620 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.018116e-01 | 0.520 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.033753e-01 | 0.394 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.033753e-01 | 0.394 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.033753e-01 | 0.394 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.033753e-01 | 0.394 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.033753e-01 | 0.394 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.538223e-01 | 0.813 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.251710e-01 | 0.647 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.251710e-01 | 0.647 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.797815e-01 | 0.553 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.605635e-01 | 0.584 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.605635e-01 | 0.584 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.605635e-01 | 0.584 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.617230e-01 | 0.442 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.617230e-01 | 0.442 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.435205e-01 | 0.613 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.282236e-01 | 0.642 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.299200e-01 | 0.482 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.816764e-01 | 0.550 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.816764e-01 | 0.550 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.451475e-01 | 0.611 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.451475e-01 | 0.611 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.451475e-01 | 0.611 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.451475e-01 | 0.611 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.805925e-01 | 0.743 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.919552e-01 | 0.717 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.031506e-01 | 0.518 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.031506e-01 | 0.518 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.282394e-01 | 0.484 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.282394e-01 | 0.484 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.282394e-01 | 0.484 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.581563e-01 | 0.446 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.581563e-01 | 0.446 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.955045e-01 | 0.403 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.955045e-01 | 0.403 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.462520e-01 | 0.350 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.462520e-01 | 0.350 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.305292e-01 | 0.275 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.305292e-01 | 0.275 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.305292e-01 | 0.275 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 5.305292e-01 | 0.275 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.305292e-01 | 0.275 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.305292e-01 | 0.275 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.920711e-01 | 0.717 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.527960e-01 | 0.452 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.527960e-01 | 0.452 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.863670e-01 | 0.413 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.863670e-01 | 0.413 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.287905e-01 | 0.368 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.287905e-01 | 0.368 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.287905e-01 | 0.368 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.774292e-01 | 0.423 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.689439e-01 | 0.433 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.873439e-01 | 0.312 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.609318e-01 | 0.443 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.583189e-01 | 0.800 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.231073e-01 | 0.491 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.020399e-01 | 0.396 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.020399e-01 | 0.396 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.421619e-01 | 0.354 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.682593e-01 | 0.774 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.265347e-01 | 0.370 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.265347e-01 | 0.370 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.131874e-01 | 0.384 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.508273e-01 | 0.346 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.695040e-01 | 0.328 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.931680e-01 | 0.307 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.931680e-01 | 0.307 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 4.931680e-01 | 0.307 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.264725e-01 | 0.279 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.264725e-01 | 0.279 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.118682e-01 | 0.506 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.570831e-01 | 0.340 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.967814e-01 | 0.401 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.963369e-01 | 0.304 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.963369e-01 | 0.304 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.966598e-01 | 0.402 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.966598e-01 | 0.402 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.239793e-01 | 0.281 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.239793e-01 | 0.281 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.984954e-01 | 0.302 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.690461e-01 | 0.329 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.690461e-01 | 0.329 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.225727e-01 | 0.282 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.225727e-01 | 0.282 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.225727e-01 | 0.282 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.635267e-01 | 0.249 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.635267e-01 | 0.249 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.635267e-01 | 0.249 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.635267e-01 | 0.249 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.882233e-01 | 0.311 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.537298e-01 | 0.257 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.209131e-01 | 0.283 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.481361e-01 | 0.261 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.444963e-01 | 0.264 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.470302e-01 | 0.262 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.823424e-01 | 0.235 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.623931e-01 | 0.250 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.759388e-01 | 0.240 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.312802e-01 | 0.365 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.518489e-01 | 0.819 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.570831e-01 | 0.340 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.352110e-01 | 0.361 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.816764e-01 | 0.550 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.031506e-01 | 0.518 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.352110e-01 | 0.361 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.249056e-01 | 0.488 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.800429e-01 | 0.553 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.239793e-01 | 0.281 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.239793e-01 | 0.281 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.733831e-01 | 0.761 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.679437e-01 | 0.330 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.114960e-01 | 0.507 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.689439e-01 | 0.433 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.444963e-01 | 0.264 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.297346e-01 | 0.639 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.677762e-01 | 0.775 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.451475e-01 | 0.611 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.451475e-01 | 0.611 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.910759e-01 | 0.408 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.994272e-01 | 0.700 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.163309e-01 | 0.500 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.038646e-01 | 0.517 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.787448e-01 | 0.320 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.567561e-01 | 0.805 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.131874e-01 | 0.384 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.863670e-01 | 0.413 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.299234e-01 | 0.638 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.690461e-01 | 0.329 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.739963e-01 | 0.562 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.073279e-01 | 0.683 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.613891e-01 | 0.792 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.911253e-01 | 0.536 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.121076e-01 | 0.506 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.543783e-01 | 0.595 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.919552e-01 | 0.717 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.014813e-01 | 0.300 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.144115e-01 | 0.383 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.131874e-01 | 0.384 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.729639e-01 | 0.242 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.823424e-01 | 0.235 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.336754e-01 | 0.631 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.483590e-01 | 0.458 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.594170e-01 | 0.444 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.911253e-01 | 0.536 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.541220e-01 | 0.256 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.264732e-01 | 0.645 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.264732e-01 | 0.645 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.935723e-01 | 0.532 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.588883e-01 | 0.799 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.518489e-01 | 0.819 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.783587e-01 | 0.749 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.036159e-01 | 0.691 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.404894e-01 | 0.619 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.537298e-01 | 0.257 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.671889e-01 | 0.573 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.264732e-01 | 0.645 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.478650e-01 | 0.830 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.589756e-01 | 0.445 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.574594e-01 | 0.803 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.073279e-01 | 0.683 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.287905e-01 | 0.368 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.144115e-01 | 0.383 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.873439e-01 | 0.312 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 4.613964e-01 | 0.336 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.639722e-01 | 0.249 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.801529e-01 | 0.744 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.523856e-01 | 0.258 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.510212e-01 | 0.821 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.299200e-01 | 0.482 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.338893e-01 | 0.631 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.510212e-01 | 0.821 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.276623e-01 | 0.485 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.462520e-01 | 0.350 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.468624e-01 | 0.460 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.817997e-01 | 0.317 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.817997e-01 | 0.317 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.570831e-01 | 0.340 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.911253e-01 | 0.536 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.456902e-01 | 0.837 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.941297e-01 | 0.712 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.033753e-01 | 0.394 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.033753e-01 | 0.394 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.462520e-01 | 0.350 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.305292e-01 | 0.275 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.287905e-01 | 0.368 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.407922e-01 | 0.468 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.144115e-01 | 0.383 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.207077e-01 | 0.494 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.931680e-01 | 0.307 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.796510e-01 | 0.421 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.036167e-01 | 0.298 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.537298e-01 | 0.257 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.419414e-01 | 0.266 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.521594e-01 | 0.453 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.266586e-01 | 0.486 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.162087e-01 | 0.665 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.444963e-01 | 0.264 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.209131e-01 | 0.283 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.001411e-01 | 0.301 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.197459e-01 | 0.658 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.284430e-01 | 0.368 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.456902e-01 | 0.837 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.264732e-01 | 0.645 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 2.816764e-01 | 0.550 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.020399e-01 | 0.396 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.987939e-01 | 0.399 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.931680e-01 | 0.307 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.813676e-01 | 0.741 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.455981e-01 | 0.837 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.802586e-01 | 0.744 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.815043e-01 | 0.551 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.247885e-01 | 0.280 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.634081e-01 | 0.579 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.630824e-01 | 0.788 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.941297e-01 | 0.712 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.959317e-01 | 0.402 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.692832e-01 | 0.771 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.134171e-01 | 0.504 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.589756e-01 | 0.445 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.802586e-01 | 0.744 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.033753e-01 | 0.394 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.033753e-01 | 0.394 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.251710e-01 | 0.647 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 3.617230e-01 | 0.442 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.462520e-01 | 0.350 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.873439e-01 | 0.312 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.264725e-01 | 0.279 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.748382e-01 | 0.323 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.442632e-01 | 0.352 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.635267e-01 | 0.249 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.481361e-01 | 0.261 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.208519e-01 | 0.283 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.470302e-01 | 0.262 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.735708e-01 | 0.241 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.130749e-01 | 0.384 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.413546e-01 | 0.467 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.679133e-01 | 0.775 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.624478e-01 | 0.789 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.508273e-01 | 0.346 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.920406e-01 | 0.535 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.403809e-01 | 0.619 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.816764e-01 | 0.550 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.648472e-01 | 0.333 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.375015e-01 | 0.270 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.588825e-01 | 0.253 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.689439e-01 | 0.433 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.624664e-01 | 0.581 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.199547e-01 | 0.658 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.955045e-01 | 0.403 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.305292e-01 | 0.275 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.635267e-01 | 0.249 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.005594e-01 | 0.522 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.925482e-01 | 0.308 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.344460e-01 | 0.272 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.251710e-01 | 0.647 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.981050e-01 | 0.526 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.811626e-01 | 0.419 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.729639e-01 | 0.242 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.479886e-01 | 0.830 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 3.617230e-01 | 0.442 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.533603e-01 | 0.452 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.481361e-01 | 0.261 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.509409e-01 | 0.259 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.054742e-01 | 0.392 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.444963e-01 | 0.264 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.941018e-01 | 0.712 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.653414e-01 | 0.782 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.014286e-01 | 0.396 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.787448e-01 | 0.320 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.537298e-01 | 0.257 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.667318e-01 | 0.247 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.012088e-01 | 0.696 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.462520e-01 | 0.350 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.349571e-01 | 0.475 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.843311e-01 | 0.315 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.506984e-01 | 0.601 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.001214e-01 | 0.523 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.003648e-01 | 0.698 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.095999e-01 | 0.679 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.926429e-01 | 0.715 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.225727e-01 | 0.282 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.764826e-01 | 0.753 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.535057e-01 | 0.596 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.567561e-01 | 0.805 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.913581e-01 | 0.718 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.723329e-01 | 0.764 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.898250e-01 | 0.310 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.713085e-01 | 0.243 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.349571e-01 | 0.475 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.227695e-01 | 0.652 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.227695e-01 | 0.652 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.147964e-01 | 0.502 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.630824e-01 | 0.788 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.941297e-01 | 0.712 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.671889e-01 | 0.573 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.959317e-01 | 0.402 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.959317e-01 | 0.402 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.597369e-01 | 0.585 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.466494e-01 | 0.608 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.589756e-01 | 0.445 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.510212e-01 | 0.821 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.561036e-01 | 0.592 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.018116e-01 | 0.520 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.617230e-01 | 0.442 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.462520e-01 | 0.350 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.462520e-01 | 0.350 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.305292e-01 | 0.275 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.305292e-01 | 0.275 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.305292e-01 | 0.275 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.305292e-01 | 0.275 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.305292e-01 | 0.275 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.451268e-01 | 0.611 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.873439e-01 | 0.312 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.873439e-01 | 0.312 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.811626e-01 | 0.419 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.635267e-01 | 0.249 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.635267e-01 | 0.249 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.763555e-01 | 0.322 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.537298e-01 | 0.257 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.073971e-01 | 0.295 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.588825e-01 | 0.253 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.823424e-01 | 0.235 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.658031e-01 | 0.247 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.130112e-01 | 0.504 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.817997e-01 | 0.317 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.911253e-01 | 0.536 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.070158e-01 | 0.513 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.873439e-01 | 0.312 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.421619e-01 | 0.354 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.570831e-01 | 0.340 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.347033e-01 | 0.475 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.888509e-01 | 0.410 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.112045e-01 | 0.386 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.823424e-01 | 0.235 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.068580e-01 | 0.513 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.419414e-01 | 0.266 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.873644e-01 | 0.542 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.873644e-01 | 0.542 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.199547e-01 | 0.658 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.621327e-01 | 0.790 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.033753e-01 | 0.394 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.462520e-01 | 0.350 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.462520e-01 | 0.350 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.163309e-01 | 0.500 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.931680e-01 | 0.307 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.561036e-01 | 0.592 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.527960e-01 | 0.452 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.773552e-01 | 0.239 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.558117e-01 | 0.592 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.692832e-01 | 0.771 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.589756e-01 | 0.445 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.617230e-01 | 0.442 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.462520e-01 | 0.350 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.462520e-01 | 0.350 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.863670e-01 | 0.413 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.264725e-01 | 0.279 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.422819e-01 | 0.616 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.533603e-01 | 0.452 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.131874e-01 | 0.384 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.823424e-01 | 0.235 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.462520e-01 | 0.350 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.449734e-01 | 0.611 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.774292e-01 | 0.423 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.471415e-01 | 0.459 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.691735e-01 | 0.433 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.720718e-01 | 0.429 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.802586e-01 | 0.744 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.282394e-01 | 0.484 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.276623e-01 | 0.485 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.239793e-01 | 0.281 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.959317e-01 | 0.402 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.264732e-01 | 0.645 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.597369e-01 | 0.585 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.674639e-01 | 0.330 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.617230e-01 | 0.442 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.299200e-01 | 0.482 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.299200e-01 | 0.482 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.816764e-01 | 0.550 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.305292e-01 | 0.275 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.144115e-01 | 0.383 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.873439e-01 | 0.312 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.613964e-01 | 0.336 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.931680e-01 | 0.307 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.418521e-01 | 0.355 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.225727e-01 | 0.282 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.031506e-01 | 0.518 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.282236e-01 | 0.642 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.829492e-01 | 0.417 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.122164e-01 | 0.673 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.541220e-01 | 0.256 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.206441e-01 | 0.283 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.667318e-01 | 0.247 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.733831e-01 | 0.761 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.561036e-01 | 0.592 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.282236e-01 | 0.642 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.010189e-01 | 0.521 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.689439e-01 | 0.433 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.537298e-01 | 0.257 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.610190e-01 | 0.251 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.020399e-01 | 0.396 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.883511e-01 | 0.411 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.282236e-01 | 0.642 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.409099e-01 | 0.467 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.287905e-01 | 0.368 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.454909e-01 | 0.610 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.589756e-01 | 0.445 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.589756e-01 | 0.445 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.674639e-01 | 0.330 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.276623e-01 | 0.485 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.305292e-01 | 0.275 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.305292e-01 | 0.275 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.613964e-01 | 0.336 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.002017e-01 | 0.699 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.823424e-01 | 0.235 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.671889e-01 | 0.573 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.959317e-01 | 0.402 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.199547e-01 | 0.658 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.264725e-01 | 0.279 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.635267e-01 | 0.249 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.435971e-01 | 0.353 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.677643e-01 | 0.775 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.299200e-01 | 0.482 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.349571e-01 | 0.475 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.617230e-01 | 0.442 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.655107e-01 | 0.781 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.537298e-01 | 0.257 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.581563e-01 | 0.446 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.873439e-01 | 0.312 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.619824e-01 | 0.791 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.537298e-01 | 0.257 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.861292e-01 | 0.232 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.861292e-01 | 0.232 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.861292e-01 | 0.232 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.861292e-01 | 0.232 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.861292e-01 | 0.232 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.861292e-01 | 0.232 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.861292e-01 | 0.232 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.861292e-01 | 0.232 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.861292e-01 | 0.232 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.861292e-01 | 0.232 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.861292e-01 | 0.232 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.861292e-01 | 0.232 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.861292e-01 | 0.232 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.861292e-01 | 0.232 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.861292e-01 | 0.232 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.883968e-01 | 0.230 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.883968e-01 | 0.230 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.893120e-01 | 0.230 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.931917e-01 | 0.227 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.945940e-01 | 0.226 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.954487e-01 | 0.225 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.970043e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.970043e-01 | 0.224 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.983682e-01 | 0.223 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.984490e-01 | 0.223 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.984490e-01 | 0.223 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.984490e-01 | 0.223 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.984490e-01 | 0.223 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.984490e-01 | 0.223 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.984490e-01 | 0.223 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.984490e-01 | 0.223 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.984490e-01 | 0.223 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.984490e-01 | 0.223 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.984490e-01 | 0.223 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.984490e-01 | 0.223 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.984490e-01 | 0.223 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.984490e-01 | 0.223 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.984490e-01 | 0.223 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.015457e-01 | 0.221 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.015457e-01 | 0.221 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.055917e-01 | 0.218 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.082606e-01 | 0.216 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.091203e-01 | 0.215 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.097608e-01 | 0.215 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.097608e-01 | 0.215 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.097608e-01 | 0.215 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.097608e-01 | 0.215 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.097608e-01 | 0.215 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.112293e-01 | 0.214 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.123464e-01 | 0.213 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.154944e-01 | 0.211 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.179463e-01 | 0.209 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.180484e-01 | 0.209 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.190463e-01 | 0.208 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.202159e-01 | 0.207 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 6.202159e-01 | 0.207 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.202159e-01 | 0.207 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.202159e-01 | 0.207 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.230886e-01 | 0.205 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.235864e-01 | 0.205 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.235864e-01 | 0.205 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.235864e-01 | 0.205 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.235864e-01 | 0.205 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.235864e-01 | 0.205 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.235864e-01 | 0.205 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.247368e-01 | 0.204 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.298742e-01 | 0.201 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.298742e-01 | 0.201 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.304412e-01 | 0.200 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.312246e-01 | 0.200 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.312246e-01 | 0.200 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.312246e-01 | 0.200 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.312246e-01 | 0.200 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.312246e-01 | 0.200 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.312246e-01 | 0.200 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.312246e-01 | 0.200 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.312246e-01 | 0.200 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.312246e-01 | 0.200 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.312246e-01 | 0.200 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.351472e-01 | 0.197 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.351472e-01 | 0.197 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.351472e-01 | 0.197 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.351472e-01 | 0.197 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.351472e-01 | 0.197 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.351472e-01 | 0.197 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.351472e-01 | 0.197 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.351472e-01 | 0.197 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.351472e-01 | 0.197 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.351472e-01 | 0.197 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.351472e-01 | 0.197 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.351472e-01 | 0.197 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.351472e-01 | 0.197 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.351472e-01 | 0.197 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.351472e-01 | 0.197 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.351472e-01 | 0.197 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.351472e-01 | 0.197 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.351472e-01 | 0.197 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.359471e-01 | 0.197 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.359471e-01 | 0.197 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.359471e-01 | 0.197 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.359471e-01 | 0.197 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.388437e-01 | 0.195 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.425674e-01 | 0.192 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.425674e-01 | 0.192 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.452596e-01 | 0.190 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.480134e-01 | 0.188 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.608796e-01 | 0.180 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.618721e-01 | 0.179 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.618721e-01 | 0.179 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.618721e-01 | 0.179 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.618721e-01 | 0.179 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.618721e-01 | 0.179 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.618721e-01 | 0.179 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.618721e-01 | 0.179 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.618721e-01 | 0.179 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.618721e-01 | 0.179 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.618721e-01 | 0.179 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.640361e-01 | 0.178 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.640361e-01 | 0.178 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.640361e-01 | 0.178 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.640361e-01 | 0.178 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.678169e-01 | 0.175 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.678169e-01 | 0.175 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.687066e-01 | 0.175 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.695866e-01 | 0.174 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.739808e-01 | 0.171 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.767019e-01 | 0.170 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.783622e-01 | 0.169 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.783622e-01 | 0.169 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.783622e-01 | 0.169 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.783622e-01 | 0.169 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.783622e-01 | 0.169 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.783622e-01 | 0.169 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.783622e-01 | 0.169 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.783622e-01 | 0.169 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.783622e-01 | 0.169 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.827031e-01 | 0.166 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.830519e-01 | 0.166 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.845506e-01 | 0.165 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.845506e-01 | 0.165 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.845506e-01 | 0.165 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.845506e-01 | 0.165 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.845506e-01 | 0.165 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.845506e-01 | 0.165 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.845506e-01 | 0.165 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.845506e-01 | 0.165 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.846078e-01 | 0.165 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.846078e-01 | 0.165 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.846078e-01 | 0.165 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.846078e-01 | 0.165 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.870865e-01 | 0.163 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.888352e-01 | 0.162 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.904358e-01 | 0.161 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.904358e-01 | 0.161 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.904358e-01 | 0.161 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.904358e-01 | 0.161 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.904358e-01 | 0.161 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 6.904358e-01 | 0.161 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.904358e-01 | 0.161 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.904358e-01 | 0.161 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.904358e-01 | 0.161 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.904358e-01 | 0.161 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.904358e-01 | 0.161 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.904358e-01 | 0.161 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.904358e-01 | 0.161 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.907022e-01 | 0.161 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.947148e-01 | 0.158 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.948844e-01 | 0.158 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.988724e-01 | 0.156 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.026440e-01 | 0.153 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.042754e-01 | 0.152 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.068463e-01 | 0.151 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.069642e-01 | 0.151 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.069642e-01 | 0.151 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.161638e-01 | 0.145 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.164608e-01 | 0.145 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.164608e-01 | 0.145 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.164608e-01 | 0.145 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.164608e-01 | 0.145 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.164608e-01 | 0.145 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.164608e-01 | 0.145 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.164608e-01 | 0.145 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.164608e-01 | 0.145 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.164608e-01 | 0.145 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.164608e-01 | 0.145 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.164608e-01 | 0.145 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.164608e-01 | 0.145 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.169792e-01 | 0.144 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.169792e-01 | 0.144 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.169792e-01 | 0.144 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.169792e-01 | 0.144 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.169792e-01 | 0.144 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.169792e-01 | 0.144 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.169792e-01 | 0.144 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.169792e-01 | 0.144 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.169792e-01 | 0.144 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.169792e-01 | 0.144 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.169792e-01 | 0.144 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.169792e-01 | 0.144 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.169792e-01 | 0.144 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.169792e-01 | 0.144 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.169868e-01 | 0.144 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.209926e-01 | 0.142 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.224074e-01 | 0.141 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.224074e-01 | 0.141 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.230385e-01 | 0.141 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.281349e-01 | 0.138 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.281349e-01 | 0.138 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.300322e-01 | 0.137 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.324143e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.373832e-01 | 0.132 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.381495e-01 | 0.132 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.388052e-01 | 0.131 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.397701e-01 | 0.131 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.409021e-01 | 0.130 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.409021e-01 | 0.130 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.415802e-01 | 0.130 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.415802e-01 | 0.130 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.415802e-01 | 0.130 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.415802e-01 | 0.130 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.415802e-01 | 0.130 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.415802e-01 | 0.130 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.466944e-01 | 0.127 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.480855e-01 | 0.126 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.480855e-01 | 0.126 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.480855e-01 | 0.126 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.483794e-01 | 0.126 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.500486e-01 | 0.125 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.500486e-01 | 0.125 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.500486e-01 | 0.125 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.500486e-01 | 0.125 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.500486e-01 | 0.125 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.500486e-01 | 0.125 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.500486e-01 | 0.125 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.500486e-01 | 0.125 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.500486e-01 | 0.125 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.500486e-01 | 0.125 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.500486e-01 | 0.125 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.500486e-01 | 0.125 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.500486e-01 | 0.125 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.500486e-01 | 0.125 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.500486e-01 | 0.125 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.502015e-01 | 0.125 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.535355e-01 | 0.123 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.535355e-01 | 0.123 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.535355e-01 | 0.123 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.545365e-01 | 0.122 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.557619e-01 | 0.122 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.571964e-01 | 0.121 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.578767e-01 | 0.120 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.643263e-01 | 0.117 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.643263e-01 | 0.117 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.643263e-01 | 0.117 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.643263e-01 | 0.117 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.643263e-01 | 0.117 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.643263e-01 | 0.117 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.643263e-01 | 0.117 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.645005e-01 | 0.117 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.653536e-01 | 0.116 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.668458e-01 | 0.115 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.668458e-01 | 0.115 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.668458e-01 | 0.115 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.668458e-01 | 0.115 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.704054e-01 | 0.113 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.739769e-01 | 0.111 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.739769e-01 | 0.111 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.782232e-01 | 0.109 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.785150e-01 | 0.109 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.796592e-01 | 0.108 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.796592e-01 | 0.108 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.796592e-01 | 0.108 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.796592e-01 | 0.108 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.796592e-01 | 0.108 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.796592e-01 | 0.108 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.796592e-01 | 0.108 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.796592e-01 | 0.108 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.796592e-01 | 0.108 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.796592e-01 | 0.108 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.796592e-01 | 0.108 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.799245e-01 | 0.108 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.799245e-01 | 0.108 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.838336e-01 | 0.106 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.844509e-01 | 0.105 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.844509e-01 | 0.105 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.844509e-01 | 0.105 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.853118e-01 | 0.105 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 7.853118e-01 | 0.105 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.853118e-01 | 0.105 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.853118e-01 | 0.105 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.853118e-01 | 0.105 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.853118e-01 | 0.105 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.853118e-01 | 0.105 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.892210e-01 | 0.103 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.892210e-01 | 0.103 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.908660e-01 | 0.102 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.960249e-01 | 0.099 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.960249e-01 | 0.099 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.996005e-01 | 0.097 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.003197e-01 | 0.097 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.005473e-01 | 0.097 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.009408e-01 | 0.096 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.009408e-01 | 0.096 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.009408e-01 | 0.096 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.009408e-01 | 0.096 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.035660e-01 | 0.095 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.036304e-01 | 0.095 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.040234e-01 | 0.095 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.046345e-01 | 0.094 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.057636e-01 | 0.094 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.057636e-01 | 0.094 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.057636e-01 | 0.094 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.057636e-01 | 0.094 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.057636e-01 | 0.094 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.057636e-01 | 0.094 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.057636e-01 | 0.094 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.057636e-01 | 0.094 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.057636e-01 | 0.094 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.057636e-01 | 0.094 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.057636e-01 | 0.094 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.069273e-01 | 0.093 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.069273e-01 | 0.093 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.069273e-01 | 0.093 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.088394e-01 | 0.092 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.158439e-01 | 0.088 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.163584e-01 | 0.088 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.163584e-01 | 0.088 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.163584e-01 | 0.088 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.172292e-01 | 0.088 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.181568e-01 | 0.087 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.223937e-01 | 0.085 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.223937e-01 | 0.085 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.250428e-01 | 0.084 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.262312e-01 | 0.083 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.287766e-01 | 0.082 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.287766e-01 | 0.082 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.287766e-01 | 0.082 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.287766e-01 | 0.082 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.287766e-01 | 0.082 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.287766e-01 | 0.082 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.287766e-01 | 0.082 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.287766e-01 | 0.082 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.287766e-01 | 0.082 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.287766e-01 | 0.082 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.287766e-01 | 0.082 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.287766e-01 | 0.082 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.300434e-01 | 0.081 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.307490e-01 | 0.081 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.318288e-01 | 0.080 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.325366e-01 | 0.080 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.386886e-01 | 0.076 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.386886e-01 | 0.076 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.386886e-01 | 0.076 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.386886e-01 | 0.076 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.386886e-01 | 0.076 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.386886e-01 | 0.076 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.386886e-01 | 0.076 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.421008e-01 | 0.075 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.421008e-01 | 0.075 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.421008e-01 | 0.075 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.433302e-01 | 0.074 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.441597e-01 | 0.074 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.441597e-01 | 0.074 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.456503e-01 | 0.073 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.465463e-01 | 0.072 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.490643e-01 | 0.071 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.490643e-01 | 0.071 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.490643e-01 | 0.071 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.490643e-01 | 0.071 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.490643e-01 | 0.071 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.490643e-01 | 0.071 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.490643e-01 | 0.071 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.534301e-01 | 0.069 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.534301e-01 | 0.069 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.536168e-01 | 0.069 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.536168e-01 | 0.069 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.536168e-01 | 0.069 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.537798e-01 | 0.069 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.541522e-01 | 0.068 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.554969e-01 | 0.068 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.591347e-01 | 0.066 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.592685e-01 | 0.066 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.592685e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.640611e-01 | 0.063 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.640611e-01 | 0.063 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.640611e-01 | 0.063 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.640611e-01 | 0.063 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.640611e-01 | 0.063 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.640611e-01 | 0.063 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.640611e-01 | 0.063 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.645731e-01 | 0.063 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.649805e-01 | 0.063 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.652693e-01 | 0.063 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.658078e-01 | 0.063 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.666675e-01 | 0.062 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.669492e-01 | 0.062 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.669492e-01 | 0.062 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.669492e-01 | 0.062 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.669492e-01 | 0.062 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.669492e-01 | 0.062 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.669492e-01 | 0.062 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.669492e-01 | 0.062 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.669492e-01 | 0.062 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.669492e-01 | 0.062 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.672734e-01 | 0.062 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.672734e-01 | 0.062 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.672734e-01 | 0.062 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.672734e-01 | 0.062 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.672734e-01 | 0.062 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.675620e-01 | 0.062 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.682331e-01 | 0.061 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.693674e-01 | 0.061 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.727287e-01 | 0.059 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.727287e-01 | 0.059 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.727287e-01 | 0.059 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.734860e-01 | 0.059 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.734860e-01 | 0.059 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.744184e-01 | 0.058 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.747596e-01 | 0.058 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.754492e-01 | 0.058 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.758924e-01 | 0.058 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.759597e-01 | 0.058 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.789919e-01 | 0.056 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.789919e-01 | 0.056 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.797501e-01 | 0.056 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.797501e-01 | 0.056 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.797501e-01 | 0.056 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.797501e-01 | 0.056 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.797501e-01 | 0.056 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.797501e-01 | 0.056 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.797501e-01 | 0.056 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.797501e-01 | 0.056 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.797501e-01 | 0.056 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.797501e-01 | 0.056 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.827157e-01 | 0.054 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.827157e-01 | 0.054 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.827157e-01 | 0.054 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.827157e-01 | 0.054 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.827157e-01 | 0.054 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.827157e-01 | 0.054 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.827157e-01 | 0.054 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.827157e-01 | 0.054 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.829428e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.833494e-01 | 0.054 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.868138e-01 | 0.052 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.886312e-01 | 0.051 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.895531e-01 | 0.051 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.895531e-01 | 0.051 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.911345e-01 | 0.050 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.911345e-01 | 0.050 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.911345e-01 | 0.050 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.911345e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.911345e-01 | 0.050 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.920677e-01 | 0.050 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.940303e-01 | 0.049 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.966148e-01 | 0.047 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.966148e-01 | 0.047 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 8.966148e-01 | 0.047 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.966148e-01 | 0.047 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.966148e-01 | 0.047 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.966148e-01 | 0.047 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.966148e-01 | 0.047 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.966148e-01 | 0.047 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.966148e-01 | 0.047 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.966148e-01 | 0.047 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.968015e-01 | 0.047 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.981904e-01 | 0.047 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.994057e-01 | 0.046 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.994057e-01 | 0.046 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.002091e-01 | 0.046 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.002091e-01 | 0.046 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.002091e-01 | 0.046 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.044265e-01 | 0.044 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.044265e-01 | 0.044 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.044265e-01 | 0.044 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.052859e-01 | 0.043 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.067218e-01 | 0.043 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.067218e-01 | 0.043 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.067256e-01 | 0.043 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.068733e-01 | 0.042 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.078035e-01 | 0.042 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.078035e-01 | 0.042 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.078035e-01 | 0.042 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.088674e-01 | 0.041 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.088674e-01 | 0.041 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.088674e-01 | 0.041 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.088674e-01 | 0.041 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.088674e-01 | 0.041 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.088674e-01 | 0.041 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.088674e-01 | 0.041 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.088674e-01 | 0.041 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.088674e-01 | 0.041 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.088674e-01 | 0.041 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.088674e-01 | 0.041 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.097043e-01 | 0.041 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.098317e-01 | 0.041 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.106283e-01 | 0.041 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.109569e-01 | 0.041 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.109569e-01 | 0.041 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.109569e-01 | 0.041 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.109569e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.146002e-01 | 0.039 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.148801e-01 | 0.039 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.148801e-01 | 0.039 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.175218e-01 | 0.037 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.175218e-01 | 0.037 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.175218e-01 | 0.037 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.181637e-01 | 0.037 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.195484e-01 | 0.036 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.195484e-01 | 0.036 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.196685e-01 | 0.036 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.196685e-01 | 0.036 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.196685e-01 | 0.036 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.196685e-01 | 0.036 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.196685e-01 | 0.036 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.196685e-01 | 0.036 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.196685e-01 | 0.036 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.196685e-01 | 0.036 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.196685e-01 | 0.036 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.206135e-01 | 0.036 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.206135e-01 | 0.036 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.210464e-01 | 0.036 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.217919e-01 | 0.035 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.256661e-01 | 0.034 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.275936e-01 | 0.033 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.275936e-01 | 0.033 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.290606e-01 | 0.032 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.291900e-01 | 0.032 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.291900e-01 | 0.032 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.291900e-01 | 0.032 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.291900e-01 | 0.032 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.291900e-01 | 0.032 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.291900e-01 | 0.032 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.291900e-01 | 0.032 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.291900e-01 | 0.032 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.291900e-01 | 0.032 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.322931e-01 | 0.030 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.341976e-01 | 0.030 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.341976e-01 | 0.030 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.342265e-01 | 0.030 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.344417e-01 | 0.029 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.344417e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.346526e-01 | 0.029 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.347312e-01 | 0.029 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.347312e-01 | 0.029 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.347312e-01 | 0.029 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.363435e-01 | 0.029 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.375835e-01 | 0.028 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.375835e-01 | 0.028 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.375835e-01 | 0.028 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.375835e-01 | 0.028 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.375835e-01 | 0.028 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.375835e-01 | 0.028 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.375835e-01 | 0.028 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.384294e-01 | 0.028 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.385684e-01 | 0.028 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.390453e-01 | 0.027 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.390453e-01 | 0.027 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.390453e-01 | 0.027 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.404024e-01 | 0.027 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.404024e-01 | 0.027 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.404389e-01 | 0.027 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.408697e-01 | 0.026 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.420150e-01 | 0.026 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.449824e-01 | 0.025 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.449824e-01 | 0.025 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.449824e-01 | 0.025 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.449824e-01 | 0.025 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.449824e-01 | 0.025 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.456141e-01 | 0.024 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.456141e-01 | 0.024 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.457382e-01 | 0.024 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.457382e-01 | 0.024 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.465469e-01 | 0.024 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.466955e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.466955e-01 | 0.024 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.466955e-01 | 0.024 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.466955e-01 | 0.024 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.480081e-01 | 0.023 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.480081e-01 | 0.023 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.488003e-01 | 0.023 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.503992e-01 | 0.022 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.503992e-01 | 0.022 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.515047e-01 | 0.022 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.515047e-01 | 0.022 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.515047e-01 | 0.022 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.515047e-01 | 0.022 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.516998e-01 | 0.022 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.517187e-01 | 0.021 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.519715e-01 | 0.021 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.545763e-01 | 0.020 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.545763e-01 | 0.020 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.547892e-01 | 0.020 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.553783e-01 | 0.020 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.558396e-01 | 0.020 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.561002e-01 | 0.019 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.567461e-01 | 0.019 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.572541e-01 | 0.019 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.572541e-01 | 0.019 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.572541e-01 | 0.019 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.572541e-01 | 0.019 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.572541e-01 | 0.019 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.572541e-01 | 0.019 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.572541e-01 | 0.019 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.572541e-01 | 0.019 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.588134e-01 | 0.018 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.599281e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.599281e-01 | 0.018 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.610640e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.610640e-01 | 0.017 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.610640e-01 | 0.017 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.610640e-01 | 0.017 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.619906e-01 | 0.017 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.623222e-01 | 0.017 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.623222e-01 | 0.017 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.623222e-01 | 0.017 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.623222e-01 | 0.017 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.623222e-01 | 0.017 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.623222e-01 | 0.017 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.629433e-01 | 0.016 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.630151e-01 | 0.016 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.630151e-01 | 0.016 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.649664e-01 | 0.015 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.649664e-01 | 0.015 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.649664e-01 | 0.015 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.649664e-01 | 0.015 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.658735e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.665067e-01 | 0.015 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.667896e-01 | 0.015 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.667896e-01 | 0.015 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.667896e-01 | 0.015 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.667896e-01 | 0.015 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.667896e-01 | 0.015 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.667896e-01 | 0.015 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.667896e-01 | 0.015 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.684911e-01 | 0.014 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.684911e-01 | 0.014 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.689066e-01 | 0.014 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.689596e-01 | 0.014 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.690443e-01 | 0.014 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.690443e-01 | 0.014 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.706831e-01 | 0.013 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.707276e-01 | 0.013 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.707276e-01 | 0.013 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.707276e-01 | 0.013 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.707276e-01 | 0.013 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.707276e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.715122e-01 | 0.013 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.716728e-01 | 0.012 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.720091e-01 | 0.012 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.734832e-01 | 0.012 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.741988e-01 | 0.011 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.741988e-01 | 0.011 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.745432e-01 | 0.011 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.745432e-01 | 0.011 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.745432e-01 | 0.011 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.745432e-01 | 0.011 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.745432e-01 | 0.011 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.759757e-01 | 0.011 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.763855e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.766917e-01 | 0.010 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.766917e-01 | 0.010 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.766917e-01 | 0.010 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.771314e-01 | 0.010 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.772586e-01 | 0.010 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.772586e-01 | 0.010 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.772586e-01 | 0.010 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.794640e-01 | 0.009 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.794640e-01 | 0.009 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.794640e-01 | 0.009 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.794640e-01 | 0.009 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.799556e-01 | 0.009 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.799556e-01 | 0.009 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.799556e-01 | 0.009 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.799556e-01 | 0.009 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.799556e-01 | 0.009 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.799556e-01 | 0.009 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.802746e-01 | 0.009 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.808116e-01 | 0.008 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.808116e-01 | 0.008 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.811042e-01 | 0.008 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.812208e-01 | 0.008 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.815651e-01 | 0.008 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.823330e-01 | 0.008 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.823330e-01 | 0.008 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.823330e-01 | 0.008 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.824788e-01 | 0.008 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.825944e-01 | 0.008 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.844285e-01 | 0.007 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.844285e-01 | 0.007 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.844285e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.844285e-01 | 0.007 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.844285e-01 | 0.007 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.844285e-01 | 0.007 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.847634e-01 | 0.007 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.851593e-01 | 0.006 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.851593e-01 | 0.006 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.851593e-01 | 0.006 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.860907e-01 | 0.006 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.862755e-01 | 0.006 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.862755e-01 | 0.006 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.862755e-01 | 0.006 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.867650e-01 | 0.006 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.879036e-01 | 0.005 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.879036e-01 | 0.005 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.882635e-01 | 0.005 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.883734e-01 | 0.005 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.887060e-01 | 0.005 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.893057e-01 | 0.005 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.893386e-01 | 0.005 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.893386e-01 | 0.005 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.893386e-01 | 0.005 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.894440e-01 | 0.005 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.894440e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.894440e-01 | 0.005 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.894440e-01 | 0.005 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.900456e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.901426e-01 | 0.004 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.903843e-01 | 0.004 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.904178e-01 | 0.004 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.906035e-01 | 0.004 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.906035e-01 | 0.004 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.909286e-01 | 0.004 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.910960e-01 | 0.004 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.913010e-01 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.913010e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.913010e-01 | 0.004 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.916621e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.919125e-01 | 0.004 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.920165e-01 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.920165e-01 | 0.003 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.923262e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.923663e-01 | 0.003 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.927010e-01 | 0.003 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.927315e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.928104e-01 | 0.003 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.929485e-01 | 0.003 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.931183e-01 | 0.003 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.931898e-01 | 0.003 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.935671e-01 | 0.003 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.938665e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.941664e-01 | 0.003 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.941927e-01 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.943304e-01 | 0.002 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.943304e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.943304e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.943304e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.943304e-01 | 0.002 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.943304e-01 | 0.002 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.943368e-01 | 0.002 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.945263e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.945263e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.950033e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.950033e-01 | 0.002 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.950690e-01 | 0.002 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.950690e-01 | 0.002 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.950690e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.955616e-01 | 0.002 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.955896e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.955969e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.957252e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.957252e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.960561e-01 | 0.002 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.960561e-01 | 0.002 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.961189e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.961189e-01 | 0.002 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.963209e-01 | 0.002 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.965796e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.965796e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.968484e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.968615e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.969856e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.969856e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.971702e-01 | 0.001 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.971836e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.971836e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.973129e-01 | 0.001 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.973434e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.973434e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.974493e-01 | 0.001 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.976588e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.976588e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.977014e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.979167e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.979924e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.982073e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.983976e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.983976e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.983976e-01 | 0.001 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.983994e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.983994e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.983994e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.983994e-01 | 0.001 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.985713e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.985879e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.985879e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.986390e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.986390e-01 | 0.001 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.987556e-01 | 0.001 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.987556e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.987556e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.988488e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.988823e-01 | 0.000 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.989034e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.989034e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.989581e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.990090e-01 | 0.000 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.990336e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.990336e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.991484e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.992495e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.992495e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.992495e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.992797e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.993026e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.993387e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.993720e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.994172e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.994302e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.994372e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.994629e-01 | 0.000 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.994865e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.994897e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.994897e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.995349e-01 | 0.000 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.995475e-01 | 0.000 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.996012e-01 | 0.000 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.996271e-01 | 0.000 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.996486e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.996486e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.996575e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.996783e-01 | 0.000 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.996783e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.996904e-01 | 0.000 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.997083e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.997210e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.998153e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998335e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998637e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.998697e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998723e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.998857e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998875e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999009e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999128e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999230e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999370e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999370e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.999439e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.999472e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999473e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999473e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999474e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.999501e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999501e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999524e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999664e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999690e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999757e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999781e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.999809e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999809e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999832e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999845e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999864e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999869e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999939e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999947e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999950e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999955e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999960e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999962e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999967e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999979e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999982e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999985e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999993e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999995e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999997e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999997e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999999e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.220446e-16 | 15.654 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.330669e-16 | 15.477 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.661338e-16 | 15.176 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.664535e-15 | 14.574 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.664535e-15 | 14.574 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.886580e-15 | 14.540 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.219647e-14 | 13.492 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.017409e-14 | 13.221 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.315437e-13 | 12.365 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.941603e-13 | 12.306 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.948264e-13 | 12.306 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.326717e-12 | 11.877 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.522893e-12 | 11.817 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.611267e-12 | 11.793 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.771894e-12 | 11.557 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.399503e-12 | 11.076 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.596102e-12 | 11.018 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.527934e-12 | 11.021 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.527934e-12 | 11.021 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.157041e-11 | 10.937 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.365153e-11 | 10.626 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.584366e-11 | 10.588 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.994871e-11 | 10.398 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.852219e-11 | 10.105 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.990375e-11 | 10.046 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.144607e-11 | 10.039 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.772272e-11 | 10.057 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.098091e-10 | 9.959 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.308764e-10 | 9.883 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.368750e-10 | 9.864 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.400750e-10 | 9.854 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.533446e-10 | 9.814 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.112389e-10 | 9.675 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.257944e-10 | 9.646 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.643880e-10 | 9.578 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.025957e-10 | 9.519 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.454196e-10 | 9.462 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.509898e-10 | 9.455 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.846895e-10 | 9.415 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.711657e-10 | 9.327 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.284000e-10 | 9.277 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.530937e-10 | 9.257 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.642726e-10 | 9.178 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.642726e-10 | 9.178 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.642726e-10 | 9.178 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.365890e-10 | 9.133 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.166612e-10 | 9.145 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.513734e-10 | 9.070 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.527078e-10 | 9.021 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.305771e-09 | 8.884 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.305771e-09 | 8.884 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.318053e-09 | 8.880 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.604649e-09 | 8.795 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.783505e-09 | 8.749 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.723352e-09 | 8.764 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.124958e-09 | 8.673 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.190172e-09 | 8.660 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.293870e-09 | 8.639 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.370265e-09 | 8.625 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.293870e-09 | 8.639 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.260275e-09 | 8.487 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.258363e-09 | 8.487 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.346996e-09 | 8.475 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.615222e-09 | 8.442 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.604955e-09 | 8.443 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.259467e-09 | 8.371 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.048051e-09 | 8.297 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.069327e-09 | 8.295 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.317834e-09 | 8.274 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.495346e-09 | 8.260 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.987356e-09 | 8.223 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.577893e-09 | 8.182 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.605483e-09 | 8.180 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.065562e-09 | 8.093 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.505752e-09 | 8.022 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.093408e-08 | 7.961 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.130998e-08 | 7.947 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.106808e-08 | 7.956 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.171496e-08 | 7.931 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.219403e-08 | 7.914 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.280773e-08 | 7.893 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.495700e-08 | 7.825 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.480003e-08 | 7.830 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.083563e-08 | 7.681 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.272775e-08 | 7.643 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.305724e-08 | 7.481 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.207003e-08 | 7.494 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.305724e-08 | 7.481 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.235603e-08 | 7.490 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.578830e-08 | 7.446 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.846569e-08 | 7.415 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.861967e-08 | 7.413 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.525804e-08 | 7.344 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.665332e-08 | 7.331 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.785770e-08 | 7.320 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.808796e-08 | 7.318 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.402638e-08 | 7.267 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.717620e-08 | 7.243 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.627638e-08 | 7.179 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.560942e-08 | 7.121 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.815154e-08 | 7.107 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.671572e-08 | 7.062 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.108085e-08 | 7.041 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.006985e-07 | 6.997 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.120012e-07 | 6.951 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.141544e-07 | 6.943 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.241046e-07 | 6.906 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.241046e-07 | 6.906 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.241703e-07 | 6.906 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.241703e-07 | 6.906 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.571551e-07 | 6.804 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.661601e-07 | 6.779 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.661601e-07 | 6.779 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.691896e-07 | 6.772 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.951917e-07 | 6.710 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.000714e-07 | 6.699 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.029902e-07 | 6.693 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.315769e-07 | 6.635 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.315769e-07 | 6.635 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.287185e-07 | 6.641 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.287185e-07 | 6.641 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.076550e-07 | 6.512 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.086829e-07 | 6.510 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.914012e-07 | 6.407 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.936563e-07 | 6.405 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.195722e-07 | 6.377 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.746855e-07 | 6.324 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.409837e-07 | 6.267 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.290212e-07 | 6.201 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.101273e-07 | 6.149 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.698888e-07 | 6.174 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.129643e-07 | 6.147 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.361611e-07 | 6.078 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.065202e-07 | 6.043 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.395843e-07 | 6.027 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.002602e-06 | 5.999 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.202196e-06 | 5.920 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.207957e-06 | 5.918 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.309554e-06 | 5.883 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.360563e-06 | 5.866 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.533968e-06 | 5.814 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.549935e-06 | 5.810 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.724709e-06 | 5.763 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.904826e-06 | 5.720 | 0 | 0 |
| Translation | R-HSA-72766 | 2.188983e-06 | 5.660 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.272203e-06 | 5.644 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.286230e-06 | 5.641 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.304857e-06 | 5.637 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.879981e-06 | 5.541 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.887463e-06 | 5.539 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.945962e-06 | 5.531 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.011185e-06 | 5.521 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.209884e-06 | 5.494 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.322031e-06 | 5.479 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.093041e-06 | 5.388 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.826167e-06 | 5.316 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.797064e-06 | 5.319 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.298800e-06 | 5.276 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.679569e-06 | 5.246 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.325398e-06 | 5.199 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.435247e-06 | 5.191 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.333184e-06 | 5.135 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.633120e-06 | 5.064 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.633120e-06 | 5.064 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.148781e-06 | 5.039 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.757778e-06 | 5.011 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.092570e-05 | 4.962 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.096399e-05 | 4.960 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.239859e-05 | 4.907 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.298977e-05 | 4.886 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.328849e-05 | 4.877 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.663192e-05 | 4.779 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.560179e-05 | 4.807 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.588879e-05 | 4.799 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.817731e-05 | 4.740 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.820743e-05 | 4.740 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.925054e-05 | 4.716 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.248242e-05 | 4.648 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.293709e-05 | 4.639 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.577884e-05 | 4.589 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.614179e-05 | 4.583 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.614179e-05 | 4.583 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.722889e-05 | 4.565 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.769967e-05 | 4.558 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.918242e-05 | 4.535 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.929440e-05 | 4.533 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.227755e-05 | 4.491 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.303119e-05 | 4.481 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.454920e-05 | 4.462 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.507822e-05 | 4.455 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.094281e-05 | 4.388 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.960740e-05 | 4.402 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.960740e-05 | 4.402 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.280617e-05 | 4.368 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.567396e-05 | 4.254 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.844146e-05 | 4.233 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.356978e-05 | 4.197 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.376857e-05 | 4.195 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.995199e-05 | 4.155 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.098755e-05 | 4.149 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.307101e-05 | 4.136 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.455860e-05 | 4.128 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.243119e-05 | 4.034 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.819075e-05 | 4.008 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.136207e-04 | 3.945 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.156658e-04 | 3.937 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.260688e-04 | 3.899 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.721875e-04 | 3.764 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.557372e-04 | 3.808 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.557372e-04 | 3.808 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.720211e-04 | 3.764 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.574264e-04 | 3.803 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.509225e-04 | 3.821 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.657225e-04 | 3.781 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.982702e-04 | 3.703 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.003617e-04 | 3.698 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.121806e-04 | 3.673 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.121806e-04 | 3.673 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.121806e-04 | 3.673 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.222031e-04 | 3.653 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.244927e-04 | 3.649 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.244927e-04 | 3.649 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.352371e-04 | 3.628 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.358895e-04 | 3.627 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.555265e-04 | 3.593 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.624603e-04 | 3.581 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.738738e-04 | 3.562 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.109246e-04 | 3.507 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.130905e-04 | 3.504 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.197862e-04 | 3.495 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.224449e-04 | 3.492 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.224449e-04 | 3.492 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.395627e-04 | 3.469 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.630312e-04 | 3.440 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.818179e-04 | 3.418 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.937315e-04 | 3.405 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.972366e-04 | 3.401 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.630312e-04 | 3.440 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.679318e-04 | 3.434 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.956239e-04 | 3.403 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.702551e-04 | 3.431 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.994572e-04 | 3.399 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.523622e-04 | 3.345 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.523622e-04 | 3.345 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.523622e-04 | 3.345 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.523622e-04 | 3.345 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.587046e-04 | 3.338 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.592928e-04 | 3.338 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.912188e-04 | 3.309 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.100337e-04 | 3.292 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.398296e-04 | 3.268 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.486350e-04 | 3.261 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.486350e-04 | 3.261 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.770216e-04 | 3.239 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.002670e-04 | 3.222 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.214967e-04 | 3.207 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.424466e-04 | 3.192 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.641387e-04 | 3.178 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.752064e-04 | 3.171 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.839439e-04 | 3.165 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.934031e-04 | 3.159 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.218813e-04 | 3.142 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.306888e-04 | 3.136 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.743370e-04 | 3.111 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.945617e-04 | 3.048 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.160467e-04 | 3.038 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.308137e-04 | 3.031 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.481801e-04 | 3.023 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.075522e-03 | 2.968 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.118697e-03 | 2.951 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.222911e-03 | 2.913 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.222911e-03 | 2.913 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.222911e-03 | 2.913 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.271627e-03 | 2.896 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.311836e-03 | 2.882 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.394329e-03 | 2.856 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.635208e-03 | 2.786 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.461025e-03 | 2.835 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.370718e-03 | 2.863 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.423853e-03 | 2.847 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.634422e-03 | 2.787 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.715673e-03 | 2.766 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.715673e-03 | 2.766 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.894965e-03 | 2.722 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.062132e-03 | 2.686 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.087470e-03 | 2.680 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.087470e-03 | 2.680 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.181718e-03 | 2.661 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.187877e-03 | 2.660 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.196950e-03 | 2.658 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.331887e-03 | 2.632 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.489146e-03 | 2.604 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.612476e-03 | 2.583 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.612476e-03 | 2.583 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.830183e-03 | 2.548 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.020048e-03 | 2.520 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.025090e-03 | 2.519 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.167732e-03 | 2.499 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.219851e-03 | 2.492 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.251496e-03 | 2.488 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.274272e-03 | 2.485 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.274272e-03 | 2.485 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.292512e-03 | 2.482 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.292512e-03 | 2.482 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.292512e-03 | 2.482 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.299681e-03 | 2.482 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.349528e-03 | 2.475 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.405650e-03 | 2.468 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.405650e-03 | 2.468 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.405650e-03 | 2.468 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.405650e-03 | 2.468 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.442148e-03 | 2.463 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.605693e-03 | 2.443 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.731187e-03 | 2.428 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.731779e-03 | 2.428 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.783581e-03 | 2.422 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.783581e-03 | 2.422 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.801253e-03 | 2.420 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.059320e-03 | 2.392 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.076230e-03 | 2.390 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.106627e-03 | 2.387 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.271291e-03 | 2.369 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.382935e-03 | 2.269 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.382935e-03 | 2.269 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.154277e-03 | 2.288 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.734690e-03 | 2.325 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.734690e-03 | 2.325 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.399074e-03 | 2.357 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.552126e-03 | 2.342 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.382935e-03 | 2.269 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.382935e-03 | 2.269 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.382040e-03 | 2.358 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.486530e-03 | 2.261 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.654172e-03 | 2.248 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.658871e-03 | 2.247 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.699192e-03 | 2.244 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.716718e-03 | 2.243 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.716718e-03 | 2.243 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.716718e-03 | 2.243 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.716718e-03 | 2.243 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.954333e-03 | 2.225 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.960199e-03 | 2.225 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.960199e-03 | 2.225 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.023292e-03 | 2.220 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 6.023292e-03 | 2.220 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 6.023292e-03 | 2.220 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.264422e-03 | 2.203 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.264422e-03 | 2.203 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.576611e-03 | 2.182 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.576611e-03 | 2.182 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.576611e-03 | 2.182 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.633117e-03 | 2.178 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.707789e-03 | 2.173 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.848887e-03 | 2.164 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.862126e-03 | 2.164 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.661564e-03 | 2.116 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.661564e-03 | 2.116 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.661564e-03 | 2.116 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.661564e-03 | 2.116 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.661564e-03 | 2.116 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.811426e-03 | 2.107 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.845183e-03 | 2.105 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.097884e-03 | 2.092 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.097884e-03 | 2.092 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.355640e-03 | 2.078 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.570636e-03 | 2.067 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.725562e-03 | 2.059 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.869631e-03 | 2.052 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.869631e-03 | 2.052 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.450589e-03 | 2.025 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.460057e-03 | 2.024 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.568672e-03 | 2.019 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.620850e-03 | 2.017 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.687508e-03 | 2.014 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 9.687508e-03 | 2.014 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.017268e-02 | 1.993 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.399722e-02 | 1.854 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.399722e-02 | 1.854 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.399722e-02 | 1.854 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.399722e-02 | 1.854 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.399722e-02 | 1.854 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.399722e-02 | 1.854 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.206844e-02 | 1.918 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.206844e-02 | 1.918 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.142610e-02 | 1.942 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.063890e-02 | 1.973 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.360672e-02 | 1.866 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.231163e-02 | 1.910 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.053066e-02 | 1.978 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.142610e-02 | 1.942 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.108620e-02 | 1.955 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.166226e-02 | 1.933 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.075284e-02 | 1.968 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.203595e-02 | 1.920 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.299714e-02 | 1.886 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.369806e-02 | 1.863 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.368426e-02 | 1.864 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.352502e-02 | 1.869 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.203595e-02 | 1.920 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.267520e-02 | 1.897 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.425442e-02 | 1.846 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.425442e-02 | 1.846 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.461482e-02 | 1.835 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.499925e-02 | 1.824 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.499925e-02 | 1.824 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.499925e-02 | 1.824 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.499925e-02 | 1.824 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.499925e-02 | 1.824 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.499925e-02 | 1.824 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.545960e-02 | 1.811 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.565443e-02 | 1.805 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.590162e-02 | 1.799 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.623371e-02 | 1.790 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.623598e-02 | 1.790 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.708131e-02 | 1.767 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.752040e-02 | 1.756 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.752040e-02 | 1.756 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.752040e-02 | 1.756 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.752040e-02 | 1.756 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.752040e-02 | 1.756 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.801002e-02 | 1.744 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.801002e-02 | 1.744 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.823556e-02 | 1.739 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.858754e-02 | 1.731 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.873973e-02 | 1.727 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.912787e-02 | 1.718 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.913427e-02 | 1.718 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.913427e-02 | 1.718 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.913427e-02 | 1.718 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.038081e-02 | 1.691 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.108765e-02 | 1.676 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.162229e-02 | 1.665 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.162345e-02 | 1.665 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.197561e-02 | 1.658 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.251262e-02 | 1.648 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.268153e-02 | 1.644 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.317785e-02 | 1.635 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.317785e-02 | 1.635 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.317785e-02 | 1.635 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.346229e-02 | 1.630 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.346229e-02 | 1.630 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.414903e-02 | 1.617 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.414903e-02 | 1.617 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.510243e-02 | 1.600 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.569679e-02 | 1.590 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.569679e-02 | 1.590 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.593043e-02 | 1.586 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.745622e-02 | 1.561 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.745622e-02 | 1.561 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.794454e-02 | 1.554 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.852718e-02 | 1.545 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.865320e-02 | 1.543 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.865320e-02 | 1.543 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.971973e-02 | 1.527 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.971973e-02 | 1.527 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.982655e-02 | 1.525 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.992423e-02 | 1.524 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.992423e-02 | 1.524 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.025048e-02 | 1.519 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.025048e-02 | 1.519 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.025048e-02 | 1.519 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.047258e-02 | 1.516 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.047258e-02 | 1.516 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.048766e-02 | 1.516 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.193166e-02 | 1.496 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.226144e-02 | 1.491 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.399049e-02 | 1.469 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.422159e-02 | 1.466 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.530213e-02 | 1.452 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.530213e-02 | 1.452 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.532109e-02 | 1.452 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.578834e-02 | 1.446 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.631584e-02 | 1.440 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.643792e-02 | 1.438 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.652978e-02 | 1.437 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.667164e-02 | 1.436 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.705064e-02 | 1.431 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.716840e-02 | 1.430 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.719530e-02 | 1.430 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.749139e-02 | 1.426 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.630104e-02 | 1.249 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.630104e-02 | 1.249 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.486023e-02 | 1.348 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.754599e-02 | 1.323 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.825146e-02 | 1.235 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.410684e-02 | 1.355 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.618321e-02 | 1.336 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.069993e-02 | 1.390 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.014019e-02 | 1.300 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.069993e-02 | 1.390 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.946956e-02 | 1.306 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.014019e-02 | 1.300 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.370411e-02 | 1.359 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.370411e-02 | 1.359 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.370411e-02 | 1.359 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.370411e-02 | 1.359 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.542218e-02 | 1.343 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 4.107320e-02 | 1.386 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.489427e-02 | 1.348 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.557853e-02 | 1.255 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.107320e-02 | 1.386 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.014019e-02 | 1.300 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.014019e-02 | 1.300 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.349950e-02 | 1.362 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.803986e-02 | 1.236 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.988130e-02 | 1.302 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.754599e-02 | 1.323 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.370411e-02 | 1.359 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.967269e-02 | 1.304 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.542218e-02 | 1.343 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.718351e-02 | 1.326 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.618321e-02 | 1.336 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.833232e-02 | 1.316 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.137180e-02 | 1.289 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.946956e-02 | 1.306 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.589975e-02 | 1.253 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.589975e-02 | 1.253 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.825146e-02 | 1.235 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.150714e-02 | 1.382 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.107320e-02 | 1.386 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.120454e-02 | 1.385 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.026451e-02 | 1.220 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.073560e-02 | 1.217 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.074420e-02 | 1.216 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.168441e-02 | 1.210 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.182354e-02 | 1.209 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.208552e-02 | 1.207 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.208552e-02 | 1.207 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.263004e-02 | 1.203 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.295907e-02 | 1.201 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.323803e-02 | 1.199 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.323803e-02 | 1.199 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.497981e-02 | 1.187 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.497981e-02 | 1.187 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.578323e-02 | 1.182 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.635723e-02 | 1.178 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.662687e-02 | 1.176 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.781958e-02 | 1.169 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.894060e-02 | 1.162 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.932748e-02 | 1.159 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.110291e-02 | 1.148 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.296599e-02 | 1.137 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.314676e-02 | 1.136 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 7.361565e-02 | 1.133 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 7.361565e-02 | 1.133 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.431670e-02 | 1.129 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.431670e-02 | 1.129 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.431670e-02 | 1.129 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.436363e-02 | 1.129 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.436363e-02 | 1.129 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.436363e-02 | 1.129 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.590498e-02 | 1.120 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.590498e-02 | 1.120 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.606243e-02 | 1.119 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.623028e-02 | 1.118 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.623028e-02 | 1.118 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.623028e-02 | 1.118 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.623028e-02 | 1.118 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.667407e-02 | 1.115 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.667407e-02 | 1.115 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.833969e-02 | 1.106 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.960169e-02 | 1.099 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.965596e-02 | 1.099 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.976167e-02 | 1.098 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.088294e-02 | 1.092 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.117664e-02 | 1.091 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.117664e-02 | 1.091 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.284229e-02 | 1.082 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.284229e-02 | 1.082 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.284229e-02 | 1.082 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.395376e-02 | 1.076 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.395376e-02 | 1.076 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.395376e-02 | 1.076 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.419553e-02 | 1.075 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.419553e-02 | 1.075 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.444232e-02 | 1.073 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.444232e-02 | 1.073 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.444232e-02 | 1.073 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.544840e-02 | 1.068 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.615329e-02 | 1.065 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.839897e-02 | 1.054 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.095451e-02 | 1.041 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.100397e-02 | 1.041 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.100397e-02 | 1.041 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.100397e-02 | 1.041 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.100397e-02 | 1.041 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.178606e-02 | 1.037 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.210838e-02 | 1.036 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.210838e-02 | 1.036 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.210838e-02 | 1.036 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.221056e-02 | 1.035 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.221056e-02 | 1.035 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.221056e-02 | 1.035 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.223627e-02 | 1.035 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.254877e-02 | 1.034 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.254877e-02 | 1.034 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.254877e-02 | 1.034 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 9.254877e-02 | 1.034 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.255138e-02 | 1.034 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.421731e-02 | 1.026 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.475138e-02 | 1.023 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.475138e-02 | 1.023 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.520088e-02 | 1.021 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.520088e-02 | 1.021 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.520088e-02 | 1.021 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.520088e-02 | 1.021 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.802331e-02 | 1.009 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.802331e-02 | 1.009 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.802331e-02 | 1.009 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.806120e-02 | 1.009 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.806120e-02 | 1.009 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.806120e-02 | 1.009 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.868893e-02 | 1.006 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.001715e-01 | 0.999 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.001715e-01 | 0.999 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.001715e-01 | 0.999 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.001715e-01 | 0.999 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.006896e-01 | 0.997 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.006896e-01 | 0.997 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.006896e-01 | 0.997 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.007372e-01 | 0.997 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.039225e-01 | 0.983 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.039225e-01 | 0.983 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.045734e-01 | 0.981 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.045773e-01 | 0.981 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.045773e-01 | 0.981 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.045773e-01 | 0.981 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.051843e-01 | 0.978 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.063995e-01 | 0.973 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.066199e-01 | 0.972 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.066199e-01 | 0.972 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.066199e-01 | 0.972 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.095320e-01 | 0.960 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.096911e-01 | 0.960 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.626335e-01 | 0.789 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.626335e-01 | 0.789 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.626335e-01 | 0.789 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.626335e-01 | 0.789 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.626335e-01 | 0.789 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.626335e-01 | 0.789 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.626335e-01 | 0.789 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.288991e-01 | 0.890 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.592388e-01 | 0.798 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.592388e-01 | 0.798 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.105454e-01 | 0.956 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.105454e-01 | 0.956 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.105454e-01 | 0.956 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.907100e-01 | 0.720 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.907100e-01 | 0.720 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.907100e-01 | 0.720 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.907100e-01 | 0.720 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.907100e-01 | 0.720 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.297566e-01 | 0.887 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.297566e-01 | 0.887 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.297566e-01 | 0.887 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.500398e-01 | 0.824 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.500398e-01 | 0.824 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.712515e-01 | 0.766 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.712515e-01 | 0.766 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.712515e-01 | 0.766 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.712515e-01 | 0.766 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.712515e-01 | 0.766 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.712515e-01 | 0.766 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.712515e-01 | 0.766 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.712515e-01 | 0.766 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.342486e-01 | 0.872 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.342486e-01 | 0.872 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.342486e-01 | 0.872 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.342486e-01 | 0.872 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.342486e-01 | 0.872 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.502323e-01 | 0.823 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.502323e-01 | 0.823 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 1.502323e-01 | 0.823 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.313416e-01 | 0.882 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.158967e-01 | 0.666 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.445870e-01 | 0.840 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 1.841833e-01 | 0.735 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.020189e-01 | 0.695 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.726823e-01 | 0.763 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.726823e-01 | 0.763 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.122165e-01 | 0.950 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.122165e-01 | 0.950 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.077984e-01 | 0.682 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.609635e-01 | 0.793 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.668989e-01 | 0.778 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.841833e-01 | 0.735 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.583790e-01 | 0.800 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.190105e-01 | 0.924 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.182810e-01 | 0.661 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.391287e-01 | 0.857 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.700781e-01 | 0.769 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.700781e-01 | 0.769 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.203249e-01 | 0.657 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.186758e-01 | 0.926 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.020189e-01 | 0.695 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.391287e-01 | 0.857 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.026726e-01 | 0.693 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.592388e-01 | 0.798 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.500398e-01 | 0.824 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.583790e-01 | 0.800 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.497151e-01 | 0.825 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.186758e-01 | 0.926 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.288991e-01 | 0.890 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.026726e-01 | 0.693 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.609243e-01 | 0.793 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.445870e-01 | 0.840 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.592388e-01 | 0.798 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.342486e-01 | 0.872 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.932499e-01 | 0.714 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 1.668989e-01 | 0.778 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.467683e-01 | 0.833 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.502323e-01 | 0.823 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.907100e-01 | 0.720 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.500398e-01 | 0.824 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.313416e-01 | 0.882 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.358655e-01 | 0.867 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.342486e-01 | 0.872 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.451562e-01 | 0.838 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.198150e-01 | 0.921 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.502323e-01 | 0.823 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.501801e-01 | 0.823 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.273201e-01 | 0.895 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.297566e-01 | 0.887 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.297566e-01 | 0.887 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.500398e-01 | 0.824 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.500398e-01 | 0.824 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.342486e-01 | 0.872 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 1.502323e-01 | 0.823 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.874598e-01 | 0.727 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.609635e-01 | 0.793 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.609635e-01 | 0.793 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.497151e-01 | 0.825 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.391579e-01 | 0.856 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.903989e-01 | 0.720 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.749649e-01 | 0.757 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.203249e-01 | 0.657 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.342486e-01 | 0.872 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.370207e-01 | 0.863 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.559005e-01 | 0.807 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.501801e-01 | 0.823 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.609635e-01 | 0.793 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.297566e-01 | 0.887 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.158967e-01 | 0.666 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.191048e-01 | 0.924 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.855408e-01 | 0.732 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.487474e-01 | 0.828 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.342486e-01 | 0.872 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.202577e-01 | 0.920 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.118843e-01 | 0.674 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.609635e-01 | 0.793 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.583790e-01 | 0.800 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.210643e-01 | 0.917 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.700781e-01 | 0.769 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.719670e-01 | 0.765 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.592388e-01 | 0.798 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.907100e-01 | 0.720 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.932499e-01 | 0.714 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.186758e-01 | 0.926 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.289211e-01 | 0.890 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.391287e-01 | 0.857 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.955508e-01 | 0.709 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.611646e-01 | 0.793 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.128491e-01 | 0.672 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.848793e-01 | 0.733 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.777899e-01 | 0.750 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.158967e-01 | 0.666 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 1.726823e-01 | 0.763 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.203249e-01 | 0.657 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 1.668989e-01 | 0.778 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.836009e-01 | 0.736 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.191048e-01 | 0.924 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.209984e-01 | 0.917 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.191048e-01 | 0.924 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.592388e-01 | 0.798 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.191048e-01 | 0.924 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 2.026726e-01 | 0.693 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.611646e-01 | 0.793 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.981620e-01 | 0.703 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.194730e-01 | 0.923 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.158967e-01 | 0.666 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.313416e-01 | 0.882 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.313416e-01 | 0.882 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.391287e-01 | 0.857 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.955508e-01 | 0.709 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.208347e-01 | 0.918 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.186758e-01 | 0.926 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.726823e-01 | 0.763 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.288991e-01 | 0.890 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.136119e-01 | 0.670 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.502323e-01 | 0.823 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.020189e-01 | 0.695 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.690147e-01 | 0.772 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.105454e-01 | 0.956 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.183548e-01 | 0.661 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.020189e-01 | 0.695 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.448278e-01 | 0.839 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.927860e-01 | 0.715 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.020189e-01 | 0.695 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.607820e-01 | 0.794 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.502323e-01 | 0.823 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.229022e-01 | 0.652 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.229022e-01 | 0.652 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.229022e-01 | 0.652 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.229022e-01 | 0.652 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.229022e-01 | 0.652 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.229022e-01 | 0.652 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.229022e-01 | 0.652 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.229022e-01 | 0.652 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.276193e-01 | 0.643 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.280891e-01 | 0.642 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.337513e-01 | 0.631 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.337513e-01 | 0.631 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.337513e-01 | 0.631 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.337513e-01 | 0.631 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.337513e-01 | 0.631 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.337513e-01 | 0.631 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.337513e-01 | 0.631 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.337513e-01 | 0.631 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.337513e-01 | 0.631 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.342444e-01 | 0.630 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.350910e-01 | 0.629 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.382651e-01 | 0.623 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.390589e-01 | 0.621 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.390589e-01 | 0.621 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.390589e-01 | 0.621 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.390743e-01 | 0.621 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.390743e-01 | 0.621 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.419108e-01 | 0.616 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.461354e-01 | 0.609 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.461354e-01 | 0.609 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.461354e-01 | 0.609 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.469747e-01 | 0.607 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.490634e-01 | 0.604 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.505218e-01 | 0.601 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.523235e-01 | 0.598 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.547605e-01 | 0.594 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.554663e-01 | 0.593 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.554663e-01 | 0.593 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.554663e-01 | 0.593 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.554663e-01 | 0.593 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.564584e-01 | 0.591 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.581604e-01 | 0.588 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.582518e-01 | 0.588 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.586795e-01 | 0.587 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.586908e-01 | 0.587 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.626098e-01 | 0.581 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.626098e-01 | 0.581 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.661889e-01 | 0.575 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.661889e-01 | 0.575 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.661889e-01 | 0.575 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.670723e-01 | 0.573 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.670723e-01 | 0.573 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.670723e-01 | 0.573 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.670723e-01 | 0.573 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.684538e-01 | 0.571 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 2.712337e-01 | 0.567 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.728201e-01 | 0.564 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.730381e-01 | 0.564 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 2.775313e-01 | 0.557 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.775313e-01 | 0.557 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.824623e-01 | 0.549 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 2.862085e-01 | 0.543 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.864301e-01 | 0.543 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.864301e-01 | 0.543 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.864301e-01 | 0.543 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.864381e-01 | 0.543 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.864381e-01 | 0.543 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.881072e-01 | 0.540 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.881072e-01 | 0.540 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.881072e-01 | 0.540 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.881072e-01 | 0.540 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.881072e-01 | 0.540 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.881072e-01 | 0.540 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.881072e-01 | 0.540 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.971235e-01 | 0.527 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.971235e-01 | 0.527 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.971235e-01 | 0.527 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.971235e-01 | 0.527 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.971235e-01 | 0.527 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.971235e-01 | 0.527 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.988329e-01 | 0.525 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 2.988329e-01 | 0.525 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.988329e-01 | 0.525 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.988329e-01 | 0.525 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.988329e-01 | 0.525 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.988329e-01 | 0.525 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.988329e-01 | 0.525 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.988329e-01 | 0.525 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.988329e-01 | 0.525 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.988329e-01 | 0.525 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.988329e-01 | 0.525 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.988329e-01 | 0.525 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.008291e-01 | 0.522 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.013545e-01 | 0.521 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.048143e-01 | 0.516 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.073923e-01 | 0.512 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.109396e-01 | 0.507 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.109396e-01 | 0.507 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.166433e-01 | 0.499 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.166433e-01 | 0.499 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.168755e-01 | 0.499 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.168755e-01 | 0.499 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.168755e-01 | 0.499 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.205772e-01 | 0.494 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.205772e-01 | 0.494 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.205772e-01 | 0.494 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.205772e-01 | 0.494 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.205772e-01 | 0.494 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.205772e-01 | 0.494 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.205772e-01 | 0.494 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.208633e-01 | 0.494 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.210925e-01 | 0.493 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.263228e-01 | 0.486 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.281419e-01 | 0.484 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.320210e-01 | 0.479 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.344405e-01 | 0.476 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.351946e-01 | 0.475 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.367284e-01 | 0.473 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.367284e-01 | 0.473 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.367284e-01 | 0.473 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.367284e-01 | 0.473 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.368048e-01 | 0.473 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.422563e-01 | 0.466 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.475392e-01 | 0.459 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.475392e-01 | 0.459 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.526700e-01 | 0.453 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.526700e-01 | 0.453 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.526700e-01 | 0.453 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.526700e-01 | 0.453 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.560606e-01 | 0.448 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.566260e-01 | 0.448 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.583903e-01 | 0.446 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.583903e-01 | 0.446 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.583903e-01 | 0.446 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.583903e-01 | 0.446 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.583903e-01 | 0.446 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.583903e-01 | 0.446 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.583903e-01 | 0.446 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.583903e-01 | 0.446 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.584321e-01 | 0.446 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.584321e-01 | 0.446 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.631614e-01 | 0.440 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.698630e-01 | 0.432 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.765149e-01 | 0.424 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.765149e-01 | 0.424 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.786798e-01 | 0.422 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.787479e-01 | 0.422 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.822963e-01 | 0.418 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.822963e-01 | 0.418 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.822963e-01 | 0.418 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.842156e-01 | 0.415 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.842156e-01 | 0.415 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.842156e-01 | 0.415 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.842156e-01 | 0.415 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.842156e-01 | 0.415 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.846559e-01 | 0.415 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.849516e-01 | 0.415 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.872203e-01 | 0.412 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.872203e-01 | 0.412 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.872203e-01 | 0.412 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.963452e-01 | 0.402 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.963452e-01 | 0.402 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.963452e-01 | 0.402 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.981700e-01 | 0.400 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 3.992345e-01 | 0.399 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.013746e-01 | 0.396 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.013746e-01 | 0.396 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.028628e-01 | 0.395 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.045479e-01 | 0.393 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.048510e-01 | 0.393 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.070360e-01 | 0.390 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.128921e-01 | 0.384 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.128921e-01 | 0.384 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.128921e-01 | 0.384 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.128921e-01 | 0.384 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.128921e-01 | 0.384 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.128921e-01 | 0.384 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.128921e-01 | 0.384 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.128921e-01 | 0.384 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.128921e-01 | 0.384 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.128921e-01 | 0.384 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.128921e-01 | 0.384 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.128921e-01 | 0.384 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.150755e-01 | 0.382 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.150755e-01 | 0.382 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.150755e-01 | 0.382 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.150755e-01 | 0.382 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.150755e-01 | 0.382 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.160696e-01 | 0.381 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.194119e-01 | 0.377 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.209652e-01 | 0.376 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.224909e-01 | 0.374 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.224909e-01 | 0.374 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.293361e-01 | 0.367 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.319363e-01 | 0.365 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.319363e-01 | 0.365 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.356447e-01 | 0.361 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.389871e-01 | 0.358 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.408860e-01 | 0.356 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.417184e-01 | 0.355 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.428142e-01 | 0.354 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.451388e-01 | 0.352 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.451388e-01 | 0.352 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.451388e-01 | 0.352 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.451388e-01 | 0.352 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.550300e-01 | 0.342 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.550300e-01 | 0.342 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.550300e-01 | 0.342 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.550300e-01 | 0.342 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.550300e-01 | 0.342 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.550300e-01 | 0.342 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.560397e-01 | 0.341 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.562859e-01 | 0.341 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.627671e-01 | 0.335 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.627671e-01 | 0.335 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.627671e-01 | 0.335 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.627671e-01 | 0.335 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.627671e-01 | 0.335 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.627671e-01 | 0.335 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.627671e-01 | 0.335 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.627671e-01 | 0.335 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.627671e-01 | 0.335 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.627671e-01 | 0.335 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 4.627671e-01 | 0.335 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.627671e-01 | 0.335 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.627671e-01 | 0.335 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 4.627671e-01 | 0.335 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.627671e-01 | 0.335 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.627671e-01 | 0.335 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.741883e-01 | 0.324 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.741883e-01 | 0.324 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.742233e-01 | 0.324 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.743180e-01 | 0.324 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.743180e-01 | 0.324 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.743180e-01 | 0.324 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.743180e-01 | 0.324 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.750270e-01 | 0.323 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.750270e-01 | 0.323 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.849533e-01 | 0.314 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.896768e-01 | 0.310 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.896768e-01 | 0.310 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.930859e-01 | 0.307 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.930859e-01 | 0.307 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.952287e-01 | 0.305 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.972328e-01 | 0.303 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.008187e-01 | 0.300 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.025466e-01 | 0.299 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.025466e-01 | 0.299 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.025466e-01 | 0.299 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.027890e-01 | 0.299 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.062128e-01 | 0.296 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.069624e-01 | 0.295 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.084080e-01 | 0.294 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.084080e-01 | 0.294 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.084080e-01 | 0.294 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.084080e-01 | 0.294 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.084080e-01 | 0.294 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.084080e-01 | 0.294 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.084080e-01 | 0.294 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.084080e-01 | 0.294 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.084080e-01 | 0.294 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.084080e-01 | 0.294 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 5.084080e-01 | 0.294 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.084080e-01 | 0.294 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.084080e-01 | 0.294 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.084080e-01 | 0.294 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.106249e-01 | 0.292 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.116922e-01 | 0.291 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.118138e-01 | 0.291 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.193055e-01 | 0.285 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 5.225313e-01 | 0.282 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.297755e-01 | 0.276 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.297755e-01 | 0.276 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.297755e-01 | 0.276 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.297755e-01 | 0.276 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.299795e-01 | 0.276 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.348305e-01 | 0.272 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.401571e-01 | 0.267 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.401571e-01 | 0.267 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.423548e-01 | 0.266 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.501740e-01 | 0.259 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.501740e-01 | 0.259 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.501740e-01 | 0.259 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.501740e-01 | 0.259 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.501740e-01 | 0.259 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 5.501740e-01 | 0.259 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.501740e-01 | 0.259 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.501740e-01 | 0.259 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 5.501740e-01 | 0.259 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.501740e-01 | 0.259 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.501740e-01 | 0.259 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.559708e-01 | 0.255 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.559708e-01 | 0.255 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.559708e-01 | 0.255 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.559708e-01 | 0.255 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.559708e-01 | 0.255 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.559708e-01 | 0.255 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.559708e-01 | 0.255 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.655027e-01 | 0.248 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.748271e-01 | 0.240 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.808922e-01 | 0.236 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.808922e-01 | 0.236 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.811116e-01 | 0.236 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.811116e-01 | 0.236 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.811116e-01 | 0.236 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.826981e-01 | 0.235 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.826981e-01 | 0.235 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.881346e-01 | 0.231 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.883937e-01 | 0.230 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.883937e-01 | 0.230 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.883937e-01 | 0.230 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.883937e-01 | 0.230 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.883937e-01 | 0.230 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.883937e-01 | 0.230 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.883937e-01 | 0.230 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.883937e-01 | 0.230 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.883937e-01 | 0.230 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.883937e-01 | 0.230 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.883937e-01 | 0.230 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.883937e-01 | 0.230 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.883937e-01 | 0.230 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.883937e-01 | 0.230 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.883937e-01 | 0.230 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.883937e-01 | 0.230 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.883937e-01 | 0.230 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.883937e-01 | 0.230 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.883937e-01 | 0.230 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.883937e-01 | 0.230 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.883937e-01 | 0.230 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.911289e-01 | 0.228 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.994939e-01 | 0.222 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.994939e-01 | 0.222 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.994939e-01 | 0.222 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.994939e-01 | 0.222 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.002305e-01 | 0.222 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.003818e-01 | 0.222 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.003818e-01 | 0.222 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.051879e-01 | 0.218 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.051879e-01 | 0.218 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.051879e-01 | 0.218 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.130189e-01 | 0.213 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.148894e-01 | 0.211 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.158763e-01 | 0.211 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.192653e-01 | 0.208 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.192653e-01 | 0.208 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.233681e-01 | 0.205 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.233681e-01 | 0.205 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.233681e-01 | 0.205 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.233681e-01 | 0.205 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.233681e-01 | 0.205 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.233681e-01 | 0.205 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.233681e-01 | 0.205 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.233681e-01 | 0.205 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.233681e-01 | 0.205 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.233681e-01 | 0.205 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.233681e-01 | 0.205 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.233681e-01 | 0.205 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.233681e-01 | 0.205 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.233681e-01 | 0.205 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.233681e-01 | 0.205 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.233681e-01 | 0.205 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 6.233681e-01 | 0.205 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.233681e-01 | 0.205 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.281993e-01 | 0.202 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.281993e-01 | 0.202 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.281993e-01 | 0.202 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.281993e-01 | 0.202 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.292280e-01 | 0.201 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.318343e-01 | 0.199 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.318343e-01 | 0.199 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.318343e-01 | 0.199 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.375324e-01 | 0.195 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.383307e-01 | 0.195 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.473590e-01 | 0.189 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.473590e-01 | 0.189 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.501527e-01 | 0.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.501527e-01 | 0.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.501527e-01 | 0.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.501527e-01 | 0.187 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.501527e-01 | 0.187 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.501527e-01 | 0.187 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.501527e-01 | 0.187 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.501527e-01 | 0.187 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.551766e-01 | 0.184 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.551766e-01 | 0.184 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.551766e-01 | 0.184 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.551766e-01 | 0.184 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.553727e-01 | 0.184 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.553727e-01 | 0.184 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.553727e-01 | 0.184 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.553727e-01 | 0.184 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.553727e-01 | 0.184 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.553727e-01 | 0.184 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.553727e-01 | 0.184 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.553727e-01 | 0.184 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.553727e-01 | 0.184 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.553727e-01 | 0.184 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.553727e-01 | 0.184 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.553727e-01 | 0.184 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.553727e-01 | 0.184 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.553727e-01 | 0.184 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.624435e-01 | 0.179 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.624435e-01 | 0.179 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.700090e-01 | 0.174 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.710618e-01 | 0.173 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.710618e-01 | 0.173 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.710618e-01 | 0.173 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.721949e-01 | 0.173 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.770830e-01 | 0.169 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.770830e-01 | 0.169 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.828670e-01 | 0.166 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.832323e-01 | 0.165 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.846594e-01 | 0.165 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.846594e-01 | 0.165 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.846594e-01 | 0.165 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.846594e-01 | 0.165 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.846594e-01 | 0.165 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.846594e-01 | 0.165 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.846594e-01 | 0.165 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.846594e-01 | 0.165 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.846594e-01 | 0.165 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.846594e-01 | 0.165 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.876698e-01 | 0.163 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.885871e-01 | 0.162 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.885871e-01 | 0.162 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.885871e-01 | 0.162 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.909455e-01 | 0.161 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.909455e-01 | 0.161 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.909455e-01 | 0.161 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.909455e-01 | 0.161 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.912745e-01 | 0.160 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.912745e-01 | 0.160 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.912745e-01 | 0.160 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.930608e-01 | 0.159 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.964589e-01 | 0.157 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.964589e-01 | 0.157 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.043560e-01 | 0.152 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.098271e-01 | 0.149 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.098271e-01 | 0.149 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.098271e-01 | 0.149 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.098271e-01 | 0.149 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.114589e-01 | 0.148 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.114589e-01 | 0.148 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.114589e-01 | 0.148 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.114589e-01 | 0.148 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.114589e-01 | 0.148 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.114589e-01 | 0.148 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.114589e-01 | 0.148 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.114589e-01 | 0.148 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.114589e-01 | 0.148 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.114589e-01 | 0.148 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.195067e-01 | 0.143 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.195067e-01 | 0.143 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.195067e-01 | 0.143 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.233267e-01 | 0.141 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.273195e-01 | 0.138 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.277333e-01 | 0.138 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.281985e-01 | 0.138 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.311552e-01 | 0.136 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.311552e-01 | 0.136 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.316737e-01 | 0.136 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.327603e-01 | 0.135 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.359822e-01 | 0.133 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.359822e-01 | 0.133 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.359822e-01 | 0.133 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.359822e-01 | 0.133 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.359822e-01 | 0.133 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.359822e-01 | 0.133 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.359822e-01 | 0.133 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.359822e-01 | 0.133 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.379124e-01 | 0.132 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.407881e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.410008e-01 | 0.130 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.429040e-01 | 0.129 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.442231e-01 | 0.128 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.479845e-01 | 0.126 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.533453e-01 | 0.123 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.555165e-01 | 0.122 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.584226e-01 | 0.120 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.584226e-01 | 0.120 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.584226e-01 | 0.120 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.584226e-01 | 0.120 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.584226e-01 | 0.120 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.584226e-01 | 0.120 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.584226e-01 | 0.120 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.584226e-01 | 0.120 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.584226e-01 | 0.120 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.584226e-01 | 0.120 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.584226e-01 | 0.120 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.607387e-01 | 0.119 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.607387e-01 | 0.119 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.607387e-01 | 0.119 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.607387e-01 | 0.119 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.607387e-01 | 0.119 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.607387e-01 | 0.119 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.607387e-01 | 0.119 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.607387e-01 | 0.119 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.613314e-01 | 0.118 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.613314e-01 | 0.118 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.696968e-01 | 0.114 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.733946e-01 | 0.112 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.740993e-01 | 0.111 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.759024e-01 | 0.110 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.759024e-01 | 0.110 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.788878e-01 | 0.109 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.789569e-01 | 0.108 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.789569e-01 | 0.108 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.789569e-01 | 0.108 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.789569e-01 | 0.108 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.789569e-01 | 0.108 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.789569e-01 | 0.108 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.789569e-01 | 0.108 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.789569e-01 | 0.108 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.863014e-01 | 0.104 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.863014e-01 | 0.104 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.863014e-01 | 0.104 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.863014e-01 | 0.104 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.863014e-01 | 0.104 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.888102e-01 | 0.103 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.888102e-01 | 0.103 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.902184e-01 | 0.102 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.902184e-01 | 0.102 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.902184e-01 | 0.102 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.902184e-01 | 0.102 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.902184e-01 | 0.102 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.902184e-01 | 0.102 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.977469e-01 | 0.098 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.977469e-01 | 0.098 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.977469e-01 | 0.098 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.977469e-01 | 0.098 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.977469e-01 | 0.098 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.977469e-01 | 0.098 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.977469e-01 | 0.098 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.977469e-01 | 0.098 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.977469e-01 | 0.098 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.994039e-01 | 0.097 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.000014e-01 | 0.097 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.037210e-01 | 0.095 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.037210e-01 | 0.095 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.037210e-01 | 0.095 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.037210e-01 | 0.095 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.037210e-01 | 0.095 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.089571e-01 | 0.092 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.090659e-01 | 0.092 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.090659e-01 | 0.092 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.149407e-01 | 0.089 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.149407e-01 | 0.089 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.149407e-01 | 0.089 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.149407e-01 | 0.089 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.149407e-01 | 0.089 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.149407e-01 | 0.089 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.149407e-01 | 0.089 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.149407e-01 | 0.089 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.149407e-01 | 0.089 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.164451e-01 | 0.088 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.164451e-01 | 0.088 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.164451e-01 | 0.088 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.196590e-01 | 0.086 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.204243e-01 | 0.086 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.284255e-01 | 0.082 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.284255e-01 | 0.082 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.292474e-01 | 0.081 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.306737e-01 | 0.081 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.306737e-01 | 0.081 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.306737e-01 | 0.081 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.306737e-01 | 0.081 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.306737e-01 | 0.081 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.306737e-01 | 0.081 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.306737e-01 | 0.081 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.306737e-01 | 0.081 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.306737e-01 | 0.081 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.306737e-01 | 0.081 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.306737e-01 | 0.081 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.306737e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.355833e-01 | 0.078 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.361260e-01 | 0.078 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.396965e-01 | 0.076 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.396965e-01 | 0.076 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.444436e-01 | 0.073 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.447655e-01 | 0.073 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.450700e-01 | 0.073 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.450700e-01 | 0.073 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.450700e-01 | 0.073 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.450700e-01 | 0.073 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.450700e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.450700e-01 | 0.073 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.458771e-01 | 0.073 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.458771e-01 | 0.073 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.484758e-01 | 0.071 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.484758e-01 | 0.071 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.492367e-01 | 0.071 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.502202e-01 | 0.070 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.524025e-01 | 0.069 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.524025e-01 | 0.069 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.571494e-01 | 0.067 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.582431e-01 | 0.066 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.582431e-01 | 0.066 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.582431e-01 | 0.066 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 8.582431e-01 | 0.066 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.582431e-01 | 0.066 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.582431e-01 | 0.066 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.600131e-01 | 0.065 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.602460e-01 | 0.065 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.615563e-01 | 0.065 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.672859e-01 | 0.062 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.695903e-01 | 0.061 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.695903e-01 | 0.061 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.702969e-01 | 0.060 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.702969e-01 | 0.060 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.702969e-01 | 0.060 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.702969e-01 | 0.060 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.702969e-01 | 0.060 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.702969e-01 | 0.060 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 8.714188e-01 | 0.060 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.783567e-01 | 0.056 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.783567e-01 | 0.056 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.783567e-01 | 0.056 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.783567e-01 | 0.056 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 8.808610e-01 | 0.055 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.813264e-01 | 0.055 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.813264e-01 | 0.055 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.813264e-01 | 0.055 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.813264e-01 | 0.055 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.813264e-01 | 0.055 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.813264e-01 | 0.055 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.838683e-01 | 0.054 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.865760e-01 | 0.052 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.865760e-01 | 0.052 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.876317e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.876317e-01 | 0.052 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.892315e-01 | 0.051 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.910485e-01 | 0.050 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.914185e-01 | 0.050 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.914185e-01 | 0.050 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.914185e-01 | 0.050 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.914185e-01 | 0.050 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.914185e-01 | 0.050 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.914185e-01 | 0.050 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.914185e-01 | 0.050 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.927568e-01 | 0.049 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.942778e-01 | 0.049 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.942778e-01 | 0.049 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.942778e-01 | 0.049 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.963356e-01 | 0.048 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.982784e-01 | 0.047 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.982784e-01 | 0.047 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.994506e-01 | 0.046 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.006530e-01 | 0.045 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.006530e-01 | 0.045 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.006530e-01 | 0.045 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.006530e-01 | 0.045 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.006530e-01 | 0.045 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.006530e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.006530e-01 | 0.045 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.091026e-01 | 0.041 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.091026e-01 | 0.041 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.091026e-01 | 0.041 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.119682e-01 | 0.040 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.145579e-01 | 0.039 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.160722e-01 | 0.038 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.168340e-01 | 0.038 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.168340e-01 | 0.038 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.168340e-01 | 0.038 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.168340e-01 | 0.038 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.168340e-01 | 0.038 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.168340e-01 | 0.038 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.204638e-01 | 0.036 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.204638e-01 | 0.036 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.217877e-01 | 0.035 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.225046e-01 | 0.035 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.225046e-01 | 0.035 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.237679e-01 | 0.034 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.237679e-01 | 0.034 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.239083e-01 | 0.034 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.239083e-01 | 0.034 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.239083e-01 | 0.034 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.239083e-01 | 0.034 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.239083e-01 | 0.034 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.239083e-01 | 0.034 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.239083e-01 | 0.034 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.259838e-01 | 0.033 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.259838e-01 | 0.033 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.272473e-01 | 0.033 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.303811e-01 | 0.031 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.303811e-01 | 0.031 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.303811e-01 | 0.031 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.303811e-01 | 0.031 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.303811e-01 | 0.031 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.303811e-01 | 0.031 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.303811e-01 | 0.031 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.311406e-01 | 0.031 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.359422e-01 | 0.029 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.359422e-01 | 0.029 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.363037e-01 | 0.029 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.363037e-01 | 0.029 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.363037e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.363037e-01 | 0.029 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.363037e-01 | 0.029 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.363037e-01 | 0.029 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.367630e-01 | 0.028 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.367630e-01 | 0.028 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.367630e-01 | 0.028 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.399202e-01 | 0.027 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.417228e-01 | 0.026 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.417228e-01 | 0.026 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.417228e-01 | 0.026 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.417228e-01 | 0.026 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.417228e-01 | 0.026 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.417228e-01 | 0.026 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.429599e-01 | 0.026 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.436683e-01 | 0.025 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.443829e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.466811e-01 | 0.024 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.466811e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.466811e-01 | 0.024 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.472770e-01 | 0.024 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.505216e-01 | 0.022 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.512179e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.512179e-01 | 0.022 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.512179e-01 | 0.022 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.522042e-01 | 0.021 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.522042e-01 | 0.021 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.526997e-01 | 0.021 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.526997e-01 | 0.021 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.536489e-01 | 0.021 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.536489e-01 | 0.021 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.549641e-01 | 0.020 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.553689e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.553689e-01 | 0.020 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.565907e-01 | 0.019 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.587706e-01 | 0.018 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.591668e-01 | 0.018 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.591668e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.591668e-01 | 0.018 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.591668e-01 | 0.018 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.591668e-01 | 0.018 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.617205e-01 | 0.017 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.626418e-01 | 0.017 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.643541e-01 | 0.016 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.670238e-01 | 0.015 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.687303e-01 | 0.014 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.688488e-01 | 0.014 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.702859e-01 | 0.013 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.702859e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.713919e-01 | 0.013 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.713919e-01 | 0.013 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.713919e-01 | 0.013 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.716609e-01 | 0.012 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.727685e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.738271e-01 | 0.012 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.755879e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.760551e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.760551e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.760551e-01 | 0.011 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.762174e-01 | 0.010 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.777820e-01 | 0.010 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.780936e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.780936e-01 | 0.010 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.780936e-01 | 0.010 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.780936e-01 | 0.010 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.790197e-01 | 0.009 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.790197e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.799587e-01 | 0.009 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.799587e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.799587e-01 | 0.009 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.816650e-01 | 0.008 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.816650e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.816650e-01 | 0.008 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.816650e-01 | 0.008 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.819085e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.819819e-01 | 0.008 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.819819e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.822161e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.832262e-01 | 0.007 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.832262e-01 | 0.007 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.833065e-01 | 0.007 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.846546e-01 | 0.007 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.851627e-01 | 0.006 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.856778e-01 | 0.006 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.857090e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.867709e-01 | 0.006 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.871359e-01 | 0.006 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.876679e-01 | 0.005 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.879064e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.882507e-01 | 0.005 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.892515e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.894772e-01 | 0.005 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.901670e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.901670e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.901670e-01 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.902613e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.902613e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.902613e-01 | 0.004 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.916921e-01 | 0.004 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.924720e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.928650e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.928650e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.928650e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.928650e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.931133e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.937001e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.942369e-01 | 0.003 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.943093e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.945341e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.948409e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.952118e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.958805e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.965883e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.966230e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.971742e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.978371e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.978371e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.979141e-01 | 0.001 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.980215e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.980896e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.981902e-01 | 0.001 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.981902e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.985353e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.988411e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.988411e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.989247e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.989994e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.990304e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.991016e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.991888e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.991939e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.992580e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993792e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.994725e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.995250e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995515e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995655e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997361e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.997836e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997880e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998101e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998220e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.998958e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999271e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999310e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999443e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999531e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999630e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999657e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999771e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999809e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999866e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999950e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999950e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999958e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999972e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999975e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999978e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999980e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999980e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999985e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999989e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999995e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |